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SUMMARY 
 
SUMMARY  
Dietary carbohydrate consumption has been related to the prevention of type 2 
diabetes (T2DM). Two major processes have been suggested as the underlying 
mechanisms: decrease of postprandial blood glucose response and/or 
fermentation of non-digestible carbohydrates. The fermentation process was 
thought to play a role through its fermentation products short-chain fatty acids 
(SCFAs, mainly acetate, propionate and butyrate).  
We observed that in healthy men non-digestible carbohydrates taken in an 
evening meal were able to diminish postprandial blood glucose response, 
increase peripheral insulin sensitivity and suppress the glucose induced pro-
inflammatory cytokines interleukin 6 (IL 6) and tumor necrosis factor  α (TNF-α) 
the next morning (second meal effect). The increased breath hydrogen and the 
higher plasma butyrate level strongly suggested that colonic fermentation may be 
responsible for these beneficial effects, with butyrate as a possible intermediate 
factor (Chapter 1).  
As decreased insulin sensitivity and increased pro-inflammatory cytokines are 
related to the development of T2DM and cardiovascular disease, our results 
suggested that colonic fermentation might be relevant for the prevention of these 
chronic diseases and this preventive effect might be special for non-digestible 
carbohydrates, which have a specific SCFAs profile. The literature about the 
relevance of SCFAs towards insulin sensitivity and the possibility of manipulating 
the colonic fermentation to produce the optimal SCFAs profile was reviewed. 
Colonic fermentation can be manipulated by changing diet, adjusting small-
intestinal and colonic transit time, applying small intestinal enzyme inhibitors, and 
modifying the specificity and activity of colon microbiota. We hypothesized that 
the insulin sensitizing effect of SCFAs is related to the SCFAs profile. 
Manipulation of the SCFAs profile could be a target for a dietary approach to 
reduce insulin resistance and control insulin resistance related diseases. The 
(functional) foods which produce the SCFAs   profile similar to that of whole grain 
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barley kernel might be potent in prevention of insulin resistance and T2DM 
(Chapter 2).  
The metabolic effect of dietary carbohydrates is determined by the extent to 
which carbohydrates are digested in the small intestine and fermented in the 
colon. We developed a mathematic model to evaluate in vivo the degree of 
digestion and fermentation of foods rich in carbohydrates. This model provided 
us a non-invasive and feasible approach to evaluate the contribution of the 
digestion and fermentation processes to the final overall metabolic effect .With 
13C labeled foods available, we may obtain a specific fermentation index  (FI) for 
each carbohydrate food or diet. The fermentation index together with the 
glycemic index (GI) would be able to provide comprehensive information about 
the biological characteristics of carbohydrate rich foods (Chapter 3).  
The fermentability of the various non-digestible carbohydrates including 
dietary fibers is not documented in detail until now. To achieve this, analytical 
method was developed to monitor the SCFAs profile in peripheral blood and 
urine after intake of different non-digestible carbohydrates. We used this method 
to test the feasibility of changing the SCFAs profile by dietary substrates. The 
test food was labeled with stable isotopes, which enabled us to link the 
fermentation products to the test food itself. We found that SCFAs profiles in 
plasma and urine could be manipulated using various non-digestible 
carbohydrates sources (Chapter 4). 
In summary, with these new techniques to monitor colonic fermentation, we 
were able to further investigate the metabolism of non-digestible carbohydrates 
in relation to prevention of insulin resistance/type 2 diabetes. The association 
between colonic fermentation and insulin sensitivity has been supported by 
accumulating evidence. Manipulation of colonic fermentation with dietary 
carbohydrates seems a promising approach to prevent and control insulin 
resistance and its related diseases, especially T2DM.  The design of a second 
meal effect study is one of the approaches to evaluate the acute beneficial effect 
of foods rich in non-digestible carbohydrates.   
INTRODUCTION 
 
INTRODUCTION 
 
In 2000, the total number of people worldwide with diabetes was estimated to be 
171 million, which is predicted to double by 2030, the corresponding prevalence 
being 2.8% and 4.4%, respectively (1). The epidemic of obesity and T2DM was 
suggested to be related to the consumption of a high fat, high protein, and low 
carbohydrate diet, as well as lack of physical exercise and the sedentary lifestyle. 
Among all the strategies to cope with this issue, efforts have been made to find a 
dietary solution for this epidemic (2).  
What should be of concern for such a diet is calories (macronutrients intake) 
as well as properties of individual nutrients. Dietary carbohydrates, as the major 
component of our diet, have attracted increasing attention. It was found that 
enhancing the proportion of dietary carbohydrates could decrease the risk of 
developing T2DM. The T2DM prevalence is lower in people adhering to a 
vegetarian diet than that of a normal diet (3). However, different carbohydrates 
may have variable effects on energy and substrate metabolism in humans. 
Carbohydrate that significantly increase postprandial blood glucose and in 
parallel blood insulin is adverse to glucose tolerance. Therefore, what should be 
concerned is not only the amount of carbohydrate in the diet, but also the 
properties of the dietary carbohydrates (4;5).  
Different types of carbohydrates are characterized by their ability to induce 
postprandial glycemic response. This finding resulted in the creation of the 
concept of glycemic index (GI) (4). In addition, dietary carbohydrates are also 
different in content and types of non-digestible carbohydrates including non-
starch polysaccharides, resistant starch (RS), non-digestible oligosaccharides 
and sugar alcohols (6). The non-digestible part of the dietary carbohydrates as 
well as part of the digestible carbohydrates which escape the digestion in the 
small intestine will reach the colon and will be (partly) fermented by colonic 
microbiota (7;8). The physiological effect of colonic fermentation is attracting 
more and more attention. 
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For a long time, the colon was regarded merely as a storage organ which 
absorbs water and some minerals and store faeces waiting to be evacuated (9). 
The importance of the enormous number of microbiota residing in the colon and 
their complex activities has just emerged. The number of the microbiota is 1014 
which is ten times that of the total human cells (10), and the number of genes is 
100 times that of the host (11). The role this complicated colonic system can play 
on human health has just been recognized. Colon function has implications not 
only for the digestive tract, but also for the peripheral organs such as liver, 
adipose tissue and muscle through various signaling factors derived from the 
colon(7;12). 
Colonic fermentation is a complicated process which produces SCFAs, 
branch-chain fatty acids (BCFAs), CO
2, H2, CH4 and other products (7). SCFAs 
are believed to be the main intermediates between colonic fermentation and their 
peripheral effects (7;8). Acetate is one of the principal SCFAs in the colon which 
increases cholesterol synthesis after absorption. Propionate is involved in 
gluconeogenesis acting as both an inhibitor and a promoter, and has been 
shown to inhibit cholesterol synthesis. Butyrate is mainly used by colonocytes as 
an energy source and plays a role in the maintenance of colonic homeostasis. 
Butyrate is also involved into other beneficial effects such as anti-inflammation, 
anti-carcinogenesis and suppressing oxidative stress (13).  
Given the emerging relevance of the colonic system to human health, colonic 
fermentation must be taken into account when effects of dietary carbohydrates 
are concerned. As dietary carbohydrates are involved in prevention and 
treatment of T2DM (2), the study of colonic fermentation of dietary carbohydrate 
may provide valuable information for T2DM control and prevention.  
Whole grain foods might be low in GI and rich in non-digestible 
carbohydrates, and their active compounds may play an additional role, singly or 
synergistically (14). These characteristics of whole grain make it attractive as 
part of a preventive strategy towards T2DM and other life style related chronic 
diseases (16).  Therefore, we used barley as the test food. 
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There are at least three approaches to evaluate the metabolic effect of whole 
grain: a￿acute postprandial observation, b￿the design of the second meal 
effect, and c￿long term interventional trials. As we were interested in the acute 
effect of colonic fermentation, we were evaluating the effect of whole grain food 
from a second meal effect point of view because the design of this type of study 
enables us to differentiate the effect of colonic fermentation from that resulting 
from low GI of the test food. Colonic fermentation has been suggested as one of 
the mechanisms that induce the second meal effect (17-23)  
In our studies we were focusing on colonic fermentation of non-digestible 
carbohydrates, especially in relation to the production of SCFAs.  
AIM OF THIS THESIS 
 
AIM OF THIS THESIS 
 
1. To investigate the effect of colonic fermentation of non-digestible 
carbohydrates using the overnight second meal design; 
2. To develop techniques which can be used to characterize fermentability of 
non-digestible dietary carbohydrates and to monitor the SCFAs profile; 
3. To explore a dietary strategy based on colonic fermentation of non-digestible 
dietary carbohydrates for increasing insulin sensitivity. 
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SCOPE OF THIS THESIS 
 
To achieve the study aims, we designed and conducted the following 
experiments. 
 
1. The underlying mechanisms of the overnight second meal effect and the 
effect of colonic fermentation 
 
In a randomized crossover study (Appendix 1), the overnight second meal effect 
of whole barley grain compared with white bread was studied in a group of 
healthy men (n=10). The mechanisms of the overnight second meal effect were 
explored, and the relevance of colonic fermentation was investigated.  
 
2. The relevance of colonic fermentation to T2DM prevention  
 
The relevance of SCFAs towards insulin sensitivity, and the possibility of 
manipulating colonic fermentation to produce the optimal profile of SCFAs  were 
reviewed. The potential of preventing insulin resistance and T2DM through 
manipulation of colonic fermentation was discussed based on our own results 
and the available evidence in the literature (Appendix 2).  
 
3. Mathematical model approach to evaluate the degree of digestion and 
fermentation of food rich in non-digestible carbohydrates 
 
A study was designed and conducted in healthy volunteers (n=17) to investigate 
the possibility that obtaining information about food digestion and fermentation in 
a non-invasive and feasible way (Appendix 3). 
13C labeled whole grain barley 
was used as a model food, breath H2 and 
13CO2 were monitored and a 
mathematical model was developed to estimate the degree of digestion and 
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fermentation of dietary carbohydrate. 
 
4. The plasma and urine SCFAs profiles of various non-digestible 
carbohydrates 
 
The plasma and urine SCFAs profiles of non-digestible carbohydrates was 
investigated in healthy volunteers (n=5) (Appendix 4). This method allowed 
monitoring of SCFAs profiles in plasma and urine after ingestion of food rich in 
non-digestible carbohydrates. This study showed the possibility to manipulate the 
plasma and urine SCFAs by using various non-digestible carbohydrates sources. 
  
RESULTS AND DISCUSSION 
 
RESULTS AND DISCUSSION 
 
1. The second meal effects 
 
The effects of an evening meal on the metabolism of the subsequent breakfast 
were investigated (Appendix 1). Compared with white bread evening meal (WB), 
the barley kernel evening meal (BA) improved glucose tolerance in healthy 
young men the next morning. The plasma glucose response after the glucose 
drink was 29 % lower after the BA evening meal (P = 0.019). The change of 
insulin response was not statistically significant. The diminished postprandial 
glucose response and unchanged insulin response after BA was in line with 
results of other authors (17;18;21;22).  
The blood glucose kinetics during oral glucose tolerance test (OGTT) was 
monitored using the double-label stable isotope technique. This technique 
enable the measurement of systemic rate of appearance of total glucose (RaT), 
endogenous glucose production (EGP), systemic rate of appearance of 
exogenous glucose (RaE), and glucose clearance rate (GCR), which reflect the 
total influx rate of glucose into blood circulation, the glucose influx from liver, the 
glucose influx from intestinal absorption, and the rate that glucose is cleared from 
blood circulation, respectively.  It was found that the GCR after BA was 
significantly higher (23 %, P = 0.016) than that of WB, but RaT, EGP, and RaE 
were the same. The net blood glucose was determined by the influx and the 
clearance. As the influx, i.e., RaT, was the same, whereas the clearance, i.e., 
GCR, was higher for BA than that of BW, the net blood glucose should be lower 
for BA than that of WB. This was exactly what was observed by the 
measurement of blood glucose.  
Because the insulin response was the same for BA and WB, the increased 
GCR could be the outcome of improved insulin sensitivity, or the outcome of 
other factors which can play an insulin-like role. It was proposed that insulin 
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sensitivity can be measured during an OGTT (24). According to this approach we 
calculated the insulin sensitivity index (ISI) after BA and WB. We found a higher 
ISI for BA compared with that of WB. 
It has been reported  that the second meal effect of a barley evening meal 
compared with a white bread evening meal was mediated by suppressed free 
fatty acids (FFA) (20-23;25) and delayed gastric emptying after the barley meal 
(20). We didn’t find different FFA for the two evening meals, and the gastric 
emptying was not expected to be different because we observed the same RaE 
for both BA and WB. Also we observed a higher plasma butyrate for BA (103 % 
higher 0-2 h incremental area under the curve (iAUC), P = 0.041) which indicated 
a higher colonic fermentation, as also shown by higher breath hydrogen for BA. 
Therefore, the improved GCR might be induced by butyrate. We could not 
conclude from our results a direct causal relationship between butyrate and the 
observed beneficial effect. As SCFAs are the main products of colonic 
fermentation, they were the focus of this thesis, but other colonic fermentation 
related factors could also be possible mediators, e.g. angiopoietin-like protein 4 
(also know as fasting-induced adipose factor), lipopolysaccharide (LPS), incretin 
hormones (26), and transformation of dietary compounds into bioactive products 
(27). 
Furthermore, moderation of plasma pro-inflammatory cytokines was seen for 
BA. After the WB, the postprandial mean IL 6 (WB vs. BA: 19.7 ± 5.1
 vs. 5.1 ± 
0.7 pg/mL, P = 0.024) and tumor necrosis TNF-α (WB vs. BA: 7.8 ± 2.1 vs. 5.3 ± 
1.6 pg/mL, P = 0.008) levels were significantly higher compared with the BA, with 
the values after the BA almost the same as the baseline values. Pro-
inflammatory cytokines can deteriorate the insulin sensitivity (28). This should not 
be the case in our study since the significant difference of both IL 6 and TNF-α 
occurred during postprandial 0-4 h rather than 0-2 h, although the change of the 
pro-inflammatory profile in our study might have relevance to the insulin 
sensitivity in the long run. In contrast, except for glucose, the significant 
differences for butyrate, and GCR occurred during postprandial 0-2 h. The iAUC 
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for glucose remained significantly different after 2 h. It was shown that high blood 
glucose can induce pro-inflammatory cytokines secretion (29). Therefore, the 
higher pro-inflammatory cytokines could be resulted from the higher blood 
glucose, whereas the moderated pro-inflammation might be due to butyrate or 
other fermentation related factors 
In order to understand the underlying mechanisms in relation to the 
fermentation processes we addressed the following questions: 
 
-a. What was the fermentable substrate when given barley kernels? 
-b. What was the fermentation site?  
-c. Why did the fermentation increase following the ingestion of the breakfast? 
 
a. What was the fermentable substrate when given barley kernels？ 
 
We have to realize that the oral-cecal transit time (OCTT) plays in important role 
in answering this question. The OCTT for similar barley kernel test meals was 4 
h (Appendix 3). In this study, the evening meal was ingested for 10 h when the 
subsequent breakfast was ingested. But during sleep, the OCTT was possibly 
slower than when subjects are active. We didn’t know how slow it was in this 
experimental situation since we didn’t monitor the OCTT to avoid disturbing 
sleeping, but an OCTT of 10 h is possible. In addition, it was found that barley is 
rich in soluble dietary fiber and RS, and the relative intact physical structure of 
barley kernel may reduce the availability of the substrate to the digestive 
enzymes, subsequently increased the undigested starch reaching colon (30). 
This implies that the carbohydrate fraction reaching the colon to be fermented 
might be more than that estimated based on the RS and dietary fiber (DF) 
measurement. 
Furthermore, most of the methods for OCTT measurement reflect only the 
time when the head of the digesta reaches caecum. It takes longer time for all 
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the digesta to arrive at the caecum. The realistic situation could be that there is 
always some digesta at the end of the ileum 10 h after intake of the evening 
meal. In addition, the way the digesta transfers from the terminal ileum to 
caecum might imply that there is still some digesta waiting at the end of the ileum 
to be propelled to the caecum. The ileocolonic transit increased postprandially 
and slowed down during fasting (31). Therefore, the fermentable substrate in the 
morning is possibly still from the evening test meal. This should be proven in a 
future study by applying stable isotope labeled evening meal and measuring the 
OCTT of the evening meal with feasible methods, for example, a smartpill (32) , 
a wireless device which monitors luminal pH and pressure. 
 
 b. What was the fermentation site? 
 
Upon the arrival of the digesta at the colon, most of the fermentation occurs at 
the ascending colon. It was found that 12 h after intake of a solid meal, most of 
the ingested meal was in the ascending colon (33). The digesta takes about 13 h 
(34) to pass the ascending colon. In addition, the movement of the colon could 
be activated by eating. The colon movement would push digesta to distal sites of 
the colon. The microbiota located in different colon sections is different. The 
digesta composition disfavored by microbiota in caecum might be the favorable 
substrate for microbiota residing in the transverse colon and beyond. There was 
also cross-feeding between microbiota  which is especially important for the 
production of butyrate (35-37). It was therefore reasonable to assume that during 
the OCTT in the morning, fermentation was increased not only in the caecum, 
but also distally, possibly in transverse colon. 
 
c. Why did the colonic fermentation increase following the ingestion of the 
breakfast?  
 
The movement of the colon is achieved by three different types of contractions 
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(38): the individual phasic contractions that include the short- and long-duration 
contraction, organized groups of contractions that include the migrating and 
nonmigrating motor complexes, and special propulsive contractions (giant 
migrating contractions). These contractions are controlled by myogenic, neural, 
and chemical mechanisms. It has been shown that eating triggers ileal 
evacuation and the movement of the colon(39;40). These eating triggered 
movements might result in the transit of digesta and make the substrate available 
for fermentation by pushing and stirring the digesta.  
The study in appendix 1 showed that colonic fermentation factors were 
related to the improved insulin sensitivity in peripheral tissues. We hypothesize 
that SCFAs, as the main products of colonic fermentation non-digestible 
carbohydrates are the possible mediators.  
 
2. Relevance of SCFA production for insulin sensitivity 
 
The association of SCFAs to insulin sensitivity, the possible mechanisms 
involved and the possibility to prevent and control insulin resistance through 
dietary manipulation of colonic fermentation were discussed in Appendix 2. The 
colonic fermentation is a complicated process because fermentation rate, site 
and pattern are all related to their physiological effects. Evidences exists that 
SCFAs have insulin sensitizing effects. The underlying mechanisms include 
suppression of pro-inflammation, improvement of FFA concentrations, and the 
direct effect of SCFAs on glucose metabolism. The available data suggested that 
the effect of SCFAs may depend on the SCFAs profile. Therefore, an optimal 
SCFAs profile is needed for the colonic fermentation to have an insulin 
sensitizing effect. Data from both in vivo and in vitro experiments showed that the 
colonic production of SCFAs could be manipulated by using different substrates, 
changing transit time, and applying enzyme inhibitors. It seemed that 
manipulation of colonic fermentation could be an effective approach to prevent 
insulin resistance and insulin resistance related diseases. 
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The availability of the fermentation substrate is dependent mainly on the 
amount and type of dietary carbohydrate. The caecum has the most abundant 
substrate for fermentation due to its anatomic advantage. The caecum has also 
the greatest number of microbiota. Therefore, fermentation is the most active in 
caecum (41;42). SCFAs production and absorption in caecum are also higher 
than that of the distal parts of the colon. It was believed that the production of the 
SCFAs is the determinant of the plasma SCFAs concentrations because the 
absorption capacity of the colon is far more than the colonic SCFAs 
concentrations that can be reached physiologically (43).  
The SCFAs profile is not only determined by the type of non-digestible 
carbohydrate, but also the whole gut transit. The OCTT may change SCFAs 
profile by influencing the availability of fermentation substrate, while the colonic 
transit may determine the SCFAs by changing the fermentation site. Different 
colon sites are dominated by different microbiota which may favor different 
substrate and produce a different SCFA profile. The fermentation occurring in 
colon beyond caecum may be important as colon cancer and ulcerative colitis 
are mainly occurred in the distal colon. On the one hand, the fermentation will 
determine the local SCFAs production which can influence the local colon health 
and have a systemic effect after absorption. On the other hand, spatial change of 
the fermentation site from proximal colon to distal colon also means temporal 
change of SCFAs production which may influence the SCFAs profile in the blood 
circulation. How much the host benefits from the colonic fermentation is therefore 
influenced by various factors affecting the SCFAs profile. Current available 
evidence may not be enough to define an optimal SCFAs profile. A higher total 
SCFAs concentration with higher butyrate proportion, as seen with the plasma 
profile of SCFAs derived from barley kernel (44), could be an optimal SCFAs 
profile on the basis of metabolic effects.. The relation between the SCFAs profile 
and insulin sensitivity should be further studied. Results from this type of study 
may be not only important to the prevention of insulin resistance and its related 
diseases, but also important towards other aspects of colonic fermentation, for 
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example, extraction of energy (45). 
 
3. Monitoring the ratio of digestion vs. fermentation of substrates 
 
In order to be able to manipulate colonic fermentation, it is important to know the 
fermentable part of the substrate. We developed a mathematical model to 
evaluate the degree of digestion and fermentation for a carbohydrate food 
(Appendix 3). 
Boiled barley kernel containing 50 g available carbohydrate was given to 17 
young volunteers. The breath samples were collected for 12 h to measure 
hydrogen and 
13CO2. Four hours after intake of barley, breath hydrogen started 
to increase significantly which was regarded as a sign of colonic fermentation. 
This suggested that the digesta of the test meal reached the caecum and started 
to ferment about 4 h after intake of the test meal. 
The 
13CO2 (%dose/h) increased and reached peak values 4 h after intake of 
the barley test meal. It decreased after the peak value, but was still higher than 
the baseline value 12 h later. The barley was labeled with 
13C during growth 
which implies that both the digestible part and non-digestible part of the barley 
kernel were labeled and could produce 
13CO2. Before the digesta reached the 
caecum, all the 
13CO2 came from the small intestinal digestion process, after that, 
13CO2 was also produced by colonic fermentation. With the 
13CO2 data derived 
from the digestion process a best fit curve was constructed, which subsequently 
could be used to estimate the total 
13CO2 derived from the digestion process. 
The difference between the fitted curve and the observed curve reflected the 
contribution of 
13CO2 from colonic fermentation. The results showed that 18-19% 
of the recovered 
13CO2 was from colonic fermentation. The samples were only 
collected for 12 h; the information about digestion and fermentation after 12 h 
could be estimated using the fitted and observed curve. By doing this, we found 
that the 
13CO2 levels would return to baseline after 24 h, and estimated that 24-
25% of 
13C was contributed by colonic fermentation.  
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It was suggested the energy value of dietary fiber and RS is 2 kcal/g (46). 
According to the content of dietary fiber and RS in the test meal, the energy 
contribution can be estimated to be 14.8%. The barley was ingested as boiled 
kernel. The relative intact physical and chemical structure made it possible that 
more carbohydrate may escape the small intestinal digestion and reach the colon 
for fermentation (30). In this sense, it’s reasonable that we derived a higher value 
(24-25% vs. 14.8%). 
Our results with the curve fitting model showed promising results which might 
be applied with other foods as well. With 
13C labeled foods available, we may 
obtain a specific fermentation index (FI) for each carbohydrate food or diet. The 
fermentation index together with the GI would be able to provide comprehensive 
information about the biological characteristics of carbohydrate rich foods.  
 
4. SCFAs profile in serum and urine 
 
A fermentation index would be able to reflect the fermentation characteristic in 
general, but cannot provide information about the SCFAs profile. As was 
discussed above, the SCFAs profile could be the critical determinant for its effect. 
We therefore developed a method to monitor the SCFAs profile in plasma and 
urine derived from colonic fermentation. The possibility of manipulating the 
SCFAs by using different non-digestible carbohydrates sources was investigated 
(Appendix 4). 
After ingestion of barley kernel or barley porridge test meals which provide 50 
g available carbohydrates, breath samples were collected for 6 h, blood samples 
14 h, and urine for 24 h. The OCTT estimated from breath hydrogen and 
14CO2 
was the same for both test meals, barley porridge (360 ± 47 min for H2-
measurements and 365 ± 55 min for 
14CO2-measurements) and barley kernels 
(372 ± 18 min for H2-measurements and 400 ± 0 min for 
14CO2-measurements) 
(P = 0.705 for H2-measurements and P = 0.285 for 
14CO2-measurements).  
An increase of 
13C-acetate was observed early after ingestion of the meals (< 
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6 h) for both test meals. A rise in 
13C-propionate in the fermentation phase could 
only be detected after the porridge and not after the kernels meal. An increase in 
13C-butyrate was found for both test meals in the fermentation phase and was 
higher after the barley kernels. Urine 
13C-SCFAs data were consistent with these 
observations. 
This study showed that plasma and urine SCFAs profiles of different non-
digestible carbohydrates can be monitored. The application of 
13C labeled 
substrate made it possible that the observed SCFAs could be linked to the 
specific substrate. This technique would help to indentify the causal relationship 
between SCFAs and its effect, e.g. improvement of insulin sensitivity. 
The study also provided evidence that colonic fermentation can be 
manipulated by dietary carbohydrates. It was known that soluble fiber is 
fermentable and completely used by colonic microbiota, whereas the insoluble 
fiber is less fermentable and contributes to the bulk of the feces. But the 
fermentation of soluble fiber may be affected by the presence of insoluble fiber 
and RS (47). By selecting different substrates, or combining different substrates, 
SCFAs profile of colonic fermentation can be manipulated. 
Due to the limitation to access colonic fermentation, information about colonic 
fermentation has not been widely available. Although it is critical for biological 
studies on effects of colonic fermentation, the quantitative evaluation of 
fermentation is still very difficult. Most of the studies concerning colonic 
fermentation measured SCFAs profile in faeces. The SCFAs profile in faeces 
may not be the same as that in caecum, and obviously not the same as in 
plasma. On the one hand, it was shown that the SCFAs concentration decreased 
in the order of caecum, ascending colon, transverse colon and rectum, although 
the proportion of the individual SCFA may keep stable (41). On the other hand, 
we don’t know whether the higher faeces SCFAs concentrations are the outcome 
of higher production or lower absorption. Before we have information about this, 
it would be reasonable to refer to the SCFAs of a known food for the optimal 
SCFAs.  
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Whole grain barley has been used in our studies and in the studies of others. 
Based on these results (18;21-23;48), we hypothesize that a food or diet which 
has a favorable whole-gut transit and produce a SCFAs profile similar to that of 
barley kernel are potent in prevention of T2DM.  
In conclusion, the  results in this thesis showed evidence that colonic 
metabolism of fermentable carbohydrates was related to insulin sensitivity and  
anti-inflammatory effects , which is considered as highly relevant for the 
prevention of Type 2 Diabetes .This preventive effect might be dependent on the 
quantity and quality of the SCFA profile. The quantity of the fermentation can be 
monitored by the Fermentation Index, derived from a mathematical model 
developed by us. Furthermore we were able to demonstrate that fermentation 
and thereby the SCFAs profile can be manipulated by the choice of substrates. 
Manipulating the colonic fermentation with dietary carbohydrates to produce the 
optimal SCFAs profile could play an important role in prevention of chronic 
diseases associated with decreased insulin sensitivity including T2DM and 
cardiovascular diseases.  
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Abstract 
 
Background 
Evening meals rich in non-digestible carbohydrates have been shown to lower 
postprandial glucose concentrations after ingestion of high glycemic index 
breakfasts. This phenomenon is linked to colonic fermentation of non-digestible 
carbohydrates, but the underlying mechanism is not fully elucidated.  
Objective 
We examined in which way glucose kinetics and related factors are changed 
after the breakfast due to colonic fermentation. 
Design 
In a cross-over design 10 healthy male subjects ingested as an evening meal 
white wheat bread (WB) or cooked barley kernels (BA), rich in non-digestible 
carbohydrates. In the morning after intake of 50 g 
13C-enriched glucose the dual 
isotope technique was applied to determine glucose kinetics. Plasma insulin, free 
fatty acid, interleukin 6 (IL 6), tumor necrosis factor-α (TNF-α), short-chain fatty 
acid concentrations and breath hydrogen excretion were measured.  
Results 
The plasma glucose response after the glucose drink was 29 % lower after the 
BA evening meal (P=0.019). The insulin response was the same, whereas tissue 
glucose uptake was 30 % higher (20.2±1.9 vs 15.5±1.8 mL/2h mean±SEM 
respectively,  P=0.016) after the BA evening meal, demonstrating higher 
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peripheral insulin sensitivity (P=0.001). The 4-h mean postprandial IL 6 (19.7±5.1 
vs 5.1±0.7 pg/mL, P=0.024) and TNF-α (7.8±2.1 vs 5.3±1.6 pg/mL, P=0.008) 
concentrations after the glucose drink were higher after the WB evening meal. 
Butyrate concentrations (P=0.041) as well as hydrogen excretion (P=0.005) were 
higher in the morning after the BA evening meal. 
Conclusions 
In healthy subjects factors related to colonic fermentation of non-digestible 
carbohydrates increase peripheral insulin sensitivity and moderate glucose-
associated inflammation. 
 
Introduction 
 
In observational studies whole grain foods and foods with low glycemic index 
(GI) and rich in non-digestible carbohydrates have been associated with 
decreased risk of type 2 diabetes (1) and cardiovascular disease (2).  These 
foods are thought to exert their beneficial effect by decreasing postprandial blood 
glucose response by slowing gastric emptying and/or delaying starch digestion 
and starch-derived glucose absorption. Besides this immediate postprandial 
effect, those foods have also been shown to influence blood glucose response 
following a subsequent meal. In several studies, evening meals rich in non-
digestible carbohydrates have been demonstrated to have the ability to reduce 
postprandial glucose to a high GI breakfast (3-5).This overnight second meal 
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effect is purported to be due to short-chain fatty acids (SCFA; acetate, 
propionate, butyrate) produced by fermentation of non-digestible carbohydrates 
by the colonic microbiota, even though other yet unknown mechanisms can not 
be excluded. These SCFA are rapidly absorbed from the colonic lumen and 
metabolized by colonic epithelial cells, but part of them also enter the portal and 
peripheral circulation (6). Effects of SCFA on liver metabolism have been 
reported (7) and implicated with effects on the adipose tissue metabolism (8) and 
secretome (9). Although the liver extracts approximately 75 % of acetate, 90 % of 
propionate and 95 % of butyrate from the portal vein (10) higher concentrations 
of SCFA in the peripheral circulation have been observed after ingestion of non-
digestible carbohydrates (8;11). Several hypotheses as to how SCFA mediate 
the glucose lowering effect have been postulated. SCFA may delay gastric 
emptying (12), have insulin-like properties (8), increase insulin sensitivity by 
decreasing free fatty acid concentrations (13), have anti-inflammatory effects 
(14) or promote insulin independent glucose sparing. 
Until now, mainly total blood glucose concentrations are reported after the 
high GI breakfast. This makes it difficult to examine in detail underlying 
mechanisms of the second meal effect, because total blood glucose is the net 
result of influx of exogenous glucose from the small intestine into the systemic 
circulation, endogenous glucose production and uptake of glucose into 
peripheral tissue. Therefore, we conducted a study to investigate the underlying 
glucose kinetics using the dual isotope technique. In addition, several factors 
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related to the regulation of glucose homeostasis, like free fatty acid 
concentrations, inflammation markers and adiponectin as well as plasma 
concentrations of SCFA were measured.  
 
Subjects and methods 
 
Experimental design 
The study was performed in a randomized crossover manner, with each subject 
studied on two occasions one week apart. The order of which the evening meal 
was administered first was determined by the order of recruitment. The subjects 
were asked to refrain from consuming foods enriched in 
13C, such as cane sugar, 
corn, corn products and pineapple, for the three days preceding the experiments 
and from alcohol and strenuous exercise for 24 h before each study day.  Each 
subject recorded his food consumption on the first study day and consumed the 
same food on the second study day. On both study days, the subjects were 
present at the clinical research unit from 21.30 h the evening before the 
experiment. The evening meal was taken at 22.00 h and the subjects stayed 
overnight. In this way food intake could be controlled and physical activity 
reduced. After the evening meal the subjects were fasting until the oral glucose 
tolerance test (OGTT), which started at 8.00 h in the morning. Catheters were 
inserted into veins in both forearms, one for collection of blood sample, kept 
patent with heparin (50 IE/mL) and the other for infusion of D-[6,6-
2H2] glucose 
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(98% 
2H APE) (Isotec Inc, Miamisburg, OH, USA). At the start of the experiment 
at 6.00 h (t = -120 min) one bolus of D-[6,6-
2H2]glucose solution (80 times the 
amount infused per minute) was infused and thereafter the continuous infusion of 
0.07 mg/min/kg bodyweight D-[6,6-
2H2]glucose solution started. Two hours after 
the start of the continuous infusion (t = 0) the OGTT was started with 55 g 
glucose (90 % carbohydrates) (glucose-monohydrate, Natufood, Natuproducts 
BV, Harderwijk, The Netherlands) dissolved in 250 mL of drinkable tap water. 
The glucose used was corn derived and therefore naturally labeled with 
13C, 
which is necessary to be able to apply the dual isotope technique. The 
13C 
abundance of glucose was 1.09837 atom % 
13C. Throughout the study, subjects 
relaxed by reading or watching videos, to restrict physical activity. 
Subjects 
Ten healthy Caucasian male subjects [age 21 ± 2.0 y (mean  SEM), body mass 
index 21.4 ± 1.0 kg/m
2] were recruited in Groningen, The Netherlands, by 
advertising. Start of recruitment was October 2006. The criteria for exclusion 
were use of medications, blood donation in the previous 6 months, use of 
antibiotics in the last 3 months, gastrointestinal symptoms, diabetes mellitus and 
gastrointestinal surgery. Approval was obtained from the Medical Ethics 
Committee of the University Medical Centre in Groningen and each subject gave 
written informed consent for the study.  
Evening meals 
The evening meals were either 105 g of white wheat bread (WB) or 86 g (dry 
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weight) of cooked whole barley kernels (BA). WB (Zaanse Snijder wit) was 
obtained at a local supermarket (Albert Hein, Groningen, The Netherlands). BA 
(Whole grain brown barley, Nature’s Harvest, Burton-upon-Trent, UK) was 
cooked in 250 g water with 1 g of salt for 32 min until all the water was absorbed. 
Each test meal provided 50 g available carbohydrate and was taken with 250 mL 
of drinkable tap water. It was estimated that the WB and BA contained 2 g and 
15 g non-digestible carbohydrates, respectively, as the degree of pearling of BA 
was the same as in the study of Nilsson et al (15).  
Sample collection 
Blood was collected throughout the experiment into tubes containing sodium 
fluoride/potassium oxalate. After centrifugation (1000 x g; 10 min) at 4 
oC the 
samples were stored at –20 
oC until assayed. Breath samples were collected by 
breathing through a straw into 10-mL Exetainers (Labco limited, 
Buckinghamshire, United Kingdom). Before ingestion of the breakfast 6 basal 
breath samples (-120, -90, -60, -30, -15, 0 min) and 5 basal blood samples (-90, -
60, -30, -15, 0 min) were taken. The sample of time point 0 was collected directly 
before the start of the OGTT. During the OGTT blood samples were taken every 
15 min for 2 h and every 30 min for additional 2 h. After taking a blood sample 
0.6 mL heparin (50 E/mL) was injected into the catheter to prevent blocking of 
the tube by clotting. Before taking the next blood sample the heparin was 
withdrawn with a small amount of blood and discarded.  
Analytical procedures 
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Glucose was measured with an ECA-180 glucose analyzer (Medingen, Dresden, 
Germany). The inter-assay and intra-assay coefficient of variation was 3 % and 1 
%, respectively. Insulin concentrations were measured in duplicate using a 
commercially available radioimmunoassay (Diagnostic Systems Laboratories, 
Webster, Texas, USA). The inter-assay and intra-assay coefficient of variation 
was 9.9 % and 4.5 %, respectively. The derivatization of plasma glucose to 
glucose penta-acetate for the analysis of the isotopic enrichment of plasma 
glucose is described in detail elsewhere (16). The 
13C/
12C isotope ratio 
measurement of the glucose penta-acetate derivative was determined by Gas 
Chromatography/Combustion/Isotope Ratio Mass Spectrometry (GC/C/IRMS) 
(TracerMAT, Thermo Finnigan, Bremen, Germany) and the 
2H enrichment was 
measured by Gas Chromatography/Mass Spectrometry (GC/MS) under 
conditions previously described (17;18). SCFAs were measured by GC/MS as 
described by Morrison et al (19). All plasma samples of one subject were 
analyzed in one batch to eliminate the effects of inter-batch variation. Breath 
hydrogen analysis was performed by GC (HP 6890 Agilent, Hewlett Packard Co, 
Palo Alto, USA), using a CP-Molsieve 5A column of 25 m x 0.53 mm (50 μm film 
thickness) (Chrompack International B.V., Bergen op Zoom, The Netherlands). 
Plasma FFA levels were determined with an enzymatic colorimetric method 
(NEFAC ACS-ACOD Method, Wako Chemicals, Richmond, VA, USA); samples 
were read at 540 nm on a BioTek EL 800 microplate reader (BioTek, Winooski, 
VT, USA). Plasma IL 6 and TNF-α were determined using the luminex Bio-plex 
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Cytokine Assay (Bio-Rad laboratories, Hercules, CA, USA); adiponectin was 
determined using the luminex Bio-Plex Pro Assay Diabetes (Bio-Rad 
laboratories, Hercules, CA, USA); samples were read on the Luminex 100 Total 
System (Luminex, Austin, TX, USA).  
Calculations  
Glucose kinetics 
The molar percent enrichment of [6,6-
2H2] glucose and the 
13C atom percentage 
were calculated as previously described (17) and smoothed using the Optimized 
Optimal Segments (OOPSEG) program developed by Bradley et al (20). The rate 
at which total glucose appeared in plasma (RaT) from exogenous (meal) and 
endogenous (hepatic) sources was calculated using the non-steady state 
equation of Steele (21) as modified by De Bodo (22). Identical behavior of 
labeled and unlabelled glucose molecules was assumed. The effective volume of 
distribution was assumed to be 200 mL/kg and the pool fraction value 0.75 (23). 
The systemic rate of appearance of exogenous glucose (RaE) was estimated as 
described by Tissot et al  (23) and endogenous glucose production (EGP) 
calculated by subtracting RaE from RaT (23). The glucose clearance rate (GCR) 
reflecting the insulin-mediated glucose uptake of tissue, was calculated as 
described by Schenk et al (24).  
 
Incremental areas under the curves 
In order to determine differences in glucose kinetics as well as in plasma 
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glucose, insulin, FFA and SCFA concentrations the incremental areas under the 
curves (iAUC) of 0 - 2 h and 0 - 4 h were calculated and compared. For these 
measurements also peak (nadir) concentrations or rates and time to peak (nadir) 
were compared. The time to peak (nadir) was defined as the time period 
between the intake of the glucose drink and the appearance of peak (nadir) 
plasma concentrations or rate. For the iAUC calculations the value of the fasting 
measurements was taken as the baseline value. Areas below baseline were not 
included. For the iAUC calculations of GCR, RaT and RaE, the values were 
multiplied by bodyweight. The iAUC of RaE was expressed as percentage of the 
administered dose of glucose equivalents (cum dose %). The EGP and FFA 
concentrations were suppressed after the oral glucose tolerance test. Therefore, 
the data were symmetrically transformed with the baseline as the symmetric axis 
to calculate the iAUC. For the other measurements which did not show any 
obvious rise in concentration on one occasion (breath hydrogen and plasma 
cytokines) the mean fasting and mean 0 - 2 h and 0 - 4 h postprandial values 
were calculated and compared.  
 
Insulin sensitivity 
An index for peripheral insulin sensitivity (SI) for use after OGTT was calculated 
based on the method developed by Cederholm et al (25) with some 
modifications. SI was expressed as the ratio of metabolic glucose clearance rate 
(MCR) to log mean postprandial plasma insulin. We calculated MCR as 0 - 2 h-
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iAUC of GCR (including areas below baseline) multiplied by body weight and 
divided by 1000. Cederholm et al (25) derived the MCR from plasma glucose 
measurements during the OGTT and estimates of the glucose space.  
Statistical analyses 
Data are presented as mean ± SEM. The univariate procedure of the General 
Linear Model was applied to test statistical differences, with test meal and 
sequence of the evening meal as fixed factor and subject as random factor.  All 
analyses were performed with SPSS 14.0 for Windows (release 14.0.2, SPSS 
Inc, Chicago, USA). A value of P < 0.05 was considered statistically significant. 
 
Results  
 
Plasma glucose and insulin 
The results are summarized in Table 1. In the morning after the BA evening meal 
the 0 - 2 h glucose iAUC during the OGTT was 29% smaller (P = 0.019) than that 
after the WB evening meal. Also, the 0 - 4 h iAUC and peak concentrations 
(Figure 1 A) were significantly different (P = 0.014 and P = 0.041 respectively). 
However, no differences were found between the insulin responses after both 
evening meals for any of the indices compared (Table 1, Figure 1 B).  
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Figure 1  Mean ( SEM) of incremental plasma glucose changes (delta) (A) and 
of plasma insulin concentrations (B) after a 50 g oral glucose tolerance test in the 
morning after a barley kernel (BA) or white bread (WB) evening meal. The 0 - 2 h 
and 0 - 4 h glucose iAUC were lower (P = 0.019 and P = 0.014, respectively) 
after the BA evening meal whereas that of insulin were the same (Univariate 
General Linear Model). N = 10 healthy male subjects. 
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Figure 2   Mean ( SEM) of the glucose clearance rate (GCR) after a 50 g oral 
glucose tolerance test in the morning after a barley kernel (BA) or white bread 
(WB) evening meal. The 0 - 2 h iAUC of GCR was significantly higher (P = 
0.016) after the BA evening meal. (Univariate General Linear Model). N = 10 
healthy male subjects.  
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Blood glucose kinetics 
The results are summarized in Table 1. RaT, RaE and EGP did not differ in any 
of the compared indices in the morning after the BA and WB evening meals. In 
the morning after the BA evening meal the 0 - 2 h iAUC of GCR was 30 % 
greater (P = 0.016) than after the WB evening meal. The GCR reached a peak 
value earlier after the BA than after the WB evening meal (P = 0.011) but the 
peak values were the same (P = 0.059) (Table 1, Figure 2).   
Plasma FFA  
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No differences were found in any of the compared indices for FFA concentrations 
(Table 1).  
Plasma SCFA 
Propionate, acetate and total SCFA plasma concentrations did not differ in any 
indices compared (Table 1). However, the 0 - 2 h iAUC of butyrate was 
significantly higher in the morning after the BA evening meal compared with the 
WA evening meal (P = 0.041) (Figure 3). 
Breath hydrogen 
The mean 0 - 2 h and 0 - 4 h concentrations of hydrogen during the OGTT in the 
morning after the BA evening meal were significantly higher than that after the 
WB evening meal (P = 0.005 for both) (Table 2, Figure 4).  
Plasma cytokines 
The results are summarized in Table 2. Mean postprandial 0 - 4 h concentrations 
of IL 6 (Figure 5 A) and TNF-α (Figure 5 B) were significantly higher in the 
morning after the WB evening meal than after the BA evening meal (P = 0.024 
and P = 0.008, respectively), however, mean postprandial 0 - 2 h concentrations 
not (P = 0.079 and P = 0.054, respectively). No significant differences were 
observed for adiponectin. (Table 2).  
Insulin sensitivity index 
Insulin sensitivity was significantly impaired in the morning after the WB evening 
meal compared with that following the BA evening meal (BA, 30.1 ± 1.9; WB, 
24.5 ± 1.5, P = 0.001). 
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Figure 3  Mean ( SEM) of plasma butyrate concentrations before and after a 50 
g oral glucose tolerance test in the morning after a barley kernel (BA) or white 
bread (WB) evening meal. The 0 - 2 h iAUC was significantly higher (P = 0.041) 
after the BA evening meal whereas the 0 - 4 h iAUC were the same after both 
evening meals (Univariate General Linear Model). N = 10 healthy male subjects. 
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Figure 4  Mean ( SEM) of breath hydrogen concentrations before and after a 50 
g oral glucose tolerance test in the morning after a barley kernel (BA) or white 
bread (WB) evening meal. The breath hydrogen concentrations (0 - 2 h and 0 - 4 
h postprandial) were significantly higher (P = 0.005 both) after the BA evening 
meal. (Univariate General Linear Model). N = 10 healthy male subjects.  
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Figure 5  Mean ( SEM) of plasma IL 6 concentrations (A) and TNF-α 
concentrations (B) before and after a 50 g oral glucose tolerance test in the 
morning after a barley kernel (BA) or white bread (WB) evening meal. The 0 - 2 h 
mean postprandial IL 6 and TNF-α  concentrations were the same after both 
evening meals whereas the mean 0 - 4 h mean postprandial IL 6 and TNF-α  
concentrations were lower (P = 0.024 and P = 0.008 respectively) after the BA 
evening meal (Univariate General Linear Model). N = 10 healthy male subjects.  
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Table 1  Indices reflecting the response of plasma glucose, insulin, free fatty acids (FFA), short chain fatty acids (SCFA), 
the glucose clearance rate (GCR), systemic rate of appearance of total glucose (RaT), rate of appearance of exogenous 
glucose (RaE) and endogenous glucose production (EGP) to a 50 g oral glucose tolerance test in the morning after a 
barley kernel (BA) or white bread (WB) evening meal. N = 10 healthy male subjects.  
  Fasting Values  Time to peak (min)  Peak values  iAUC
1 0 - 2 h  iAUC 0 - 4 h 
Glucose (mmol/L)  BA
2  
WB
3 
5.1 ± 0.1 
5.0 ± 0.1 
40.5 ± 3.2 
39.0 ± 2.5 
8.5 ± 0.3
a 
9.1 ± 0.4 
167.1 ± 18.9
a  
234.9 ± 29.9 
  
170.2 ± 21.1
a  
241.4 ± 30.9  
Insulin (mU/L)  BA  
WB 
6.3 ± 0.7 
5.5 ± 0.6 
40.5 ± 3.9 
43.5 ± 3.5 
72.5 ± 11.4 
70.1 ± 6.5 
3035 ± 417 
3753 ± 392 
3121 ± 431 
4057 ± 481 
RaT
4 (mg·kg
-1·min
-1)  BA  
WB 
2.5 ± 0.1 
2.5 ± 0.1 
54.0 ± 3.3 
51.0 ± 3.3 
7.1 ± 0.2 
6.6 ± 0.4 
27.0 ± 1.2 
24.7 ± 1.5 
35.7 ± 1.5  
33.0 ± 1.7  
RaE
5 (mg·kg
-1·min
-1)   BA  
WB 
0 
0 
60.0 ± 5.5 
57.0 ± 7.7 
5.3 ± 0.2 
4.8 ± 0.4 
66.2 ± 2.4 
61.5 ± 3.1 
89.7 ± 2.4 
86.7 ± 1.7 
  Fasting Values  Time to peak (min)  Peak values  iAUC
1 0 - 2 h  iAUC 0 - 4 h 
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EGP
6 (mg·kg
-1·min
-1)   BA  
WB 
2.5 ± 0.1 
2.5 ± 0.1 
90.0 ± 10.5 
99.0 ± 10.1 
1.5 ± 0.1 
1.4 ± 0.1 
86.3 ± 9.4 
85.5 ± 9.3 
142.0 ± 22.7 
148.1 ± 25.0 
GCR
7 (mL·kg
-1·min
-1) BA   
WB 
2.8 ± 0.1 
2.8 ± 0.1 
84.0 ± 7.1
a  
118.5 ± 9.1
  
8.1 ± 0.5 
7.0 ± 0.3 
20.2 ± 1.9
a  
15.5 ± 1.8
  
33.4 ± 2.6 
  
29.0 ± 2.1 
  
FFA
8 (mmol/L)  BA  
WB 
0.39 ± 0.04 
0.48 ± 0.04 
94.5 ± 3.2 
103.5 ± 6.9 
0.03 ± 0.01 
0.04 ± 0.01 
28.6 ± 3.7 
36.3 ± 3.7 
43.9 ± 6.7 
57.6 ± 6.6 
Acetate (µmol/L)  BA  
WB 
479.7 ± 61.2 
418.6 ± 47.8  
36.0 ± 6.0 
78.0 ± 19.6 
864.4 ± 207.3 
732.3 ± 117.1  
11934 ± 4601 
15389 ± 5942 
13480 ± 5259 
19782 ± 7296 
Propionate (µmol/L)  BA  
WB 
10.3 ± 0.6 
9.9 ± 0.7 
51.0 ± 11.9 
36.0 ± 4.0 
16.0 ± 1.5 
15.3 ± 1.3  
223.8 ± 41.9 
245.5 ± 39.8 
258.3 ± 44.9 
264.7 ± 42.9 
Butyrate (µmol/L)  BA  
WB 
1.8 ± 0.2 
1.6 ± 0.1 
60.0 ± 23.7 
84.0 ± 35.2 
2.9 ±  0.3 
2.6 ±  0.2 
48.6 ± 10.1
a  
23.9 ± 6.2 
  
74.7 ± 17.7 
42.4 ± 11.4 
Total SCFA
9 (µmol/L)  BA  
WB 
491.8 ± 61.5 
430.1 ± 48.1 
36.0 ± 6.0 
78.0 ± 19.6 
882.7 ± 207.3  
747.4 ± 117.3  
12330 ± 4582  
15615 ± 5969  
13883 ± 5267  
20007 ± 7311  
1 Units of the 0 - 2 h and 0 - 4 h iAUC for glucose, insulin, FFA, acetate, propionate, butyrate and total SCFA are the unit of 
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the corresponding parameter per 2 h or 4 h respectively; units of 0 - 2 h and 0 - 4 h iAUC of RaT and EGP are g per 2 h 
and g per 4 h, respectively; units of 0 - 2 h and 0 - 4 h iAUC of GCR is mL per 2 h and mL per 4 h; units of 0 - 2 h and 0 - 4 
h iAUC of RaE are %dose/2 h and %dose/4 h, respectively.  
 2barley kernel evening meal; 
3  white bread evening meal; 
4  systemic rate of appearance of total glucose; 
5 rate of 
appearance of exogenous glucose; 
6 endogenous glucose production; 
7 free fatty acids; 
8 glucose clearance rate; 
9 short 
chain fatty acids. 
a significantly different from the WB result, P < 0.05 (Univariate General Linear Model).  
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Table 2  Mean ( SEM) concentrations of breath hydrogen, plasma IL 6, TNF-α, 
and adiponectin concentrations before and after a 50 g oral glucose tolerance 
test in the morning after a barley kernel (BA) or white bread (WB) evening meal. 
N = 10 healthy male subjects. 
 
 
Fasting 
concentration 
Mean 0 - 2 h 
postprandial 
concentration 
Mean 0 - 4 h 
postprandial 
concentration 
Hydrogen (ppm)  BA
1 
WB
2 
31.5 ± 3.4 
24.4 ± 3.5 
40.0 ± 6.5
a 
15.2 ± 1.4 
39.5 ± 7.0
a 
14.2 ± 1.2 
IL 6
3 (pg/mL)  BA  
WB 
7.0 ± 0.8 
13.1 ± 4.2 
5.2 ± 0.8 
15.0 ± 4.5 
5.1 ± 0.7
a 
19.7 ± 5.1 
TNF-α
4 (pg/mL)  BA  
WB 
5.7 ± 1.9 
6.6 ± 1.8 
5.5 ± 1.8 
6.7 ± 1.7 
5.3 ± 1.6
a 
7.8 ± 2.1 
Adiponectin 
(µg/mL) 
BA  
WB 
27.0 ± 5.4 
32.0 ± 5.8 
26.5 ± 4.4 
30.4 ± 4.5 
28.3 ± 4.5 
30.6 ± 4.8 
 
1 barley kernel evening meal; 
2 white bread evening meal; 
3 interleukin 6; 
4 tumor 
necrosis factor - α;  
a significantly different from the WB result, P < 0.05 (Univariate General Linear 
Model). 
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Discussion  
 
The findings of this study elucidate in which way glucose kinetics after a high GI 
breakfast are altered due to the ingestion of an evening meal rich in non-
digestible carbohydrates and show that a glucose-associated rise in pro-
inflammatory cytokines can be moderated by the previous evening meal. 
With the dual isotope technique we were able to show that reduced glucose 
response to a 50 g OGTT after a BA evening meal was due to higher glucose 
uptake into peripheral tissue, reflected by the GCR. It also excludes possible 
effects mediated by SCFA on gastric emptying as proposed previously (12), 
because the RaE was not different. In addition, modulation of EGP does not 
seem to contribute to the reduced glucose response. 
So far, only one study investigated postprandial glucose kinetics after the 
breakfast in an overnight second meal study design with the dual isotope 
technique (26). In this study no change in GCR was found after 75 g glucose in 
the morning after an evening meal of BA as compared with brown rice. However, 
these data were only reported for one postprandial time point (60 min), which 
makes comparison with our results difficult. In the study of Thornburn et al (26) 
lower EGP was observed after the BA evening meal. The difference in EGP was 
mainly due to an initial pronounced increase of EGP 20 min after the start of the 
OGTT which occurred after the rice but not the BA evening meal. In our study, as 
well as in other studies using the same technique to determine EGP (27;28), an 
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initial increase in EGP was not observed. The differences in results could be 
either due to the characteristics of the subjects or the characteristics of the 
evening meals low in non-digestible carbohydrates. 
The higher GCR in our study was not accompanied by higher insulin 
concentrations, implying that tissue sensitivity to insulin has been higher after the 
BA evening meal. EGP was the same after both evening meals, which suggests 
that only peripheral and not hepatic insulin sensitivity was altered. We tested this 
assumption by calculating an index of peripheral insulin sensitivity (25) by using 
GCR, which was indeed significantly different. Other overnight second meal 
studies, so far, have not reported insulin sensitivity. However, the results of one 
study with a similar design are consistent with our results. Higher insulin 
sensitivity (calculated with the minimal model) in healthy subjects was found after 
a standard breakfast after administering three high resistant starch meals on the 
previous day compared with meals without resistant starch (29). Our findings are 
also in line with results of more longer term interventions, as supplementation of 
a diet with either cereal fiber enriched bread for 3 days (30) or 30 g resistant 
starch per day for 4 weeks (8) increased insulin sensitivity (measured with the 
euglycemic hyperinsulinemic clamp) in healthy subjects. The results of our study 
thus indicate that food associated factors acutely can influence peripheral insulin 
sensitivity. This is the more remarkable as the observation is made in healthy 
lean volunteers, in whom glucose homeostasis can be expected to be optimally 
regulated.  
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Breath hydrogen was higher in the morning after the BA evening meal, 
supporting the hypothesis of involvement of colonic fermentation in the overnight 
second meal effect. Furthermore, we observed 103 % higher butyrate 
concentrations in the morning after the BA evening meal, which is consistent with 
results of Nilsson et al (4) but not in agreement with the findings of two other 
studies (15;29). These inconsistencies in results could be due to differences in 
time points of sampling, characteristics of the evening meal or analytical 
methods. The study of Gao et al (31) gives an indication as to the possible 
underlying mechanisms of the insulin sensitizing effect of butyrate. In that study 
oral supplementation of butyrate (5 g/kg/day), which increased butyrate 
concentrations in serum in fed condition by 71 %, prevented development of 
insulin resistance and obesity in C57BL/6J mice on a high-fat diet. Cell culture 
experiments to explore the underlying molecular mechanisms of their 
observation showed the potency of butyrate to directly activate among others 
adenosine 5’-monophosphate activated protein kinase (AMPK). The activation of 
AMPK by pharmacological means previously has been shown to increase 
glucose transport and cell-surface glucose transporter 4 (GLUT 4) content in 
skeletal muscle from nondiabetic men (32). Thus, the results of our study 
suggest that butyrate, derived from colonic fermentation of non-digestible 
carbohydrates, could be involved in the overnight second meal effect. To prove a 
causal relationship, however, intervention studies with butyrate are necessary.  
Another novel finding of our study concerns the ability of an evening meal of 
BA to prevent the late postprandial rise in the pro-inflammatory cytokines IL 6 
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and TNF-α after the glucose load in the morning. Recently, much attention has 
been paid to inflammatory processes associated with acute hyperglycemia in 
relationship to insulin sensitivity and atherosclerotic processes. Hyperglycemia 
induced by a hyperglycemic clamp, oral glucose or high GI-meal has been 
shown to increase nuclear factor kappa B activity (NF-κB) in peripheral blood 
mononuclear cells (PBMC) in healthy lean volunteers (33-35). Nuclear factor 
kappa B (NF- κB) plays a central role in inflammatory responses and is involved 
in transcriptional regulation of many cytokines (36). In vitro, high glucose 
concentrations induce toll-like receptor 2 and 4 expression in human monocytes 
which leads to higher NF-kB activity and IL 6 and TNF-α secretion (37). Higher 
plasma concentrations of IL 6 and TNF-α were observed after plasma glucose 
concentrations have been acutely raised in a glucose clamp study in healthy 
volunteers (38) as well as in a hyperinsulinemic euglycemic clamp study (39). In 
addition IL 6 was higher postprandially after a high GI meal with no change in 
TNF-α (40). It may be of interest to note, that similar activation of NF- κB  or 
increase in IL 6 and TNF-α have also been observed after fat containing meals 
(40-42). The high glucose or meal-induced inflammatory response could be 
prevented by concomitant intake of antioxidants (glutathione, vitamine C) (34;38) 
or antioxidant rich food (olive oil, red wine) (41;43). Our observation that an 
evening meal rich in non-digestible carbohydrates can also prevent the meal-
associated rise in IL 6 the following morning is in line with the results from 
Nilsson et al (44), however the effect of a previous meal on the rise of TNF-α 
after a subsequent meal has not been examined before. Thus, our finding 
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suggests that not only concomitant intake of antioxidants but also so far 
unknown antioxidant or anti-inflammatory mechanisms or factors derived from a 
previous evening meal can moderate meal-associate inflammation.  
What governs the factors responsible for suppression of the inflammatory 
response - we only can speculate. On the one hand, this could be due to anti-
inflammatory properties of SCFA. Butyrate has been shown in vitro to decrease 
pro-inflammatory cytokine expression via inhibition of NF- κB activation in PBMC 
(45) and all three SCFA decreased lipopolysacharide-stimulated TNF-α release 
from human neutrophils (46). On the other hand, also the presence of bioactive 
compounds with anti-oxidative capacity could play a role in the observed effect. 
Many classes of phenolic compounds are present in BA which have been shown 
to have strong anti-oxidative capacity in vitro (47). Many of these bioactive 
components are bound to cell walls of the grain and reach the colon where they 
are released during the fermentation process (48). Currently, however, little 
information is available about their antioxidant effects in vivo. 
In summary, the results of our study highlight the potency of an evening meal 
rich in non-digestible carbohydrates to increase tissue glucose uptake the next 
morning, and suggest a possible role for butyrate or butyrate associated factors. 
The observation of the late anti-inflammatory effect of BA is valuable with regard 
to the exploration of new strategies to prevent high glucose or meal-induced 
postprandial inflammation.  
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Abstract 
 
Short-chain fatty acids (SCFAs) produced by colonic fermentation of non-
digestible carbohydrates have been shown to have an impact on the host in 
relation to the prevention of chronic diseases. Recent studies indicate that 
SCFAs might be able to improve insulin sensitivity in humans. The colonic SCFA 
production is affected by various factors including the presence of fermentable 
substrate, the chemical and physical properties of the substrate, the composition 
of the colon microbiota and the colon transit time. It has been suggested that the 
amount and the proportion of SCFAs (SCFA profile) are determinants of their 
physiological effect. We reviewed the evidence for a relationship between SCFA 
production and insulin sensitivity, which has impact on various chronic diseases 
and aging. The evidence showed that the insulin sensitizing effect of SCFAs 
depends on the specific SCFA profile and this profile is influenced by various 
factors related to colonic fermentation. We hypothesize that manipulating colonic 
fermentation to produce an optimal SCFA profile is a promising tool to prevent 
insulin resistance. The approaches to manipulate colonic fermentation, and the 
potential of whole grain food in this regard are discussed.  
 
Introduction 
 
The colon, which was once simply regarded as an organ of fluid retention, has 
been more and more recognized as an important metabolic organ. Colonic 
fermentation is a complicated process by which among others short-chain fatty 
acids (SCFAs), branch-chain fatty acids, CO2, CH4 and H2 (1) are produced. 
Important substrates for colonic fermentation are dietary carbohydrates that 
escape small intestinal digestion. They are (partly) fermented by colonic 
microbiota to produce SCFAs (mainly acetate, propionate and butyrate).  
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Consumption of non-digestible carbohydrates has been shown to exert 
beneficial health effects. Several studies have been conducted to investigate the 
relationship between non-digestible carbohydrates and glucose tolerance or 
insulin sensitivity. In the overnight second meal effect studies, the observation of 
improved glucose tolerance after breakfast in the morning after an evening meal 
rich in non-digestible carbohydrates indicated that colonic fermentation is likely to 
be involved in this beneficial effect (2-6;7). Improved insulin sensitivity of 
peripheral tissue was suggested as a mechanism for the second meal effect, and 
SCFAs from colonic fermentation were suggested to play a role in this insulin 
sensitizing effect (7).  
The amount and proportion of SCFAs produced (the SCFA profile) are 
determined by the type and amount of the substrate, the fermentation site, the 
rate of fermentation and absorption as well as the composition and activity of the 
colonic microbiota (8;9). All these aspects are affecting the fermentation process 
and thereby the SCFA profile. This suggests that manipulation of colonic 
fermentation to produce an optimal SCFAs profile may be a promising approach 
to prevent insulin resistance and related diseases.  
In this paper, the relevance of colonic fermentation for the prevention of 
insulin resistance and the possibility of manipulating colonic fermentation through 
dietary carbohydrates to obtain this beneficial effect were explored.   
 
The relationship between plasma SCFA concentrations 
and glucose tolerance or insulin sensitivity  
 
In several second meal effect studies improved glucose tolerance was observed 
in the morning after evening meals rich in non-digestible carbohydrates (2-6;10-
12). In addition, improved postprandial insulin sensitivity was observed in the 
morning after a barley kernel evening meal (compared with white bread) (7) and 
after consumption of four portions of resistant starch (RS) on the previous day 
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(compared with no RS-supplementation) (12). Higher concentrations of hydrogen 
in breath, an indicator of colonic fermentation of non-digestible carbohydrates, 
have been consistently observed in the morning after the evening meals rich in 
non-digestible carbohydrates, suggesting an involvement of colonic fermentation 
in the observed effect.  Plasma concentration of SCFAs, however were only 
measured in four studies (3;6;7;12). Two of these studies (6;7)reported higher 
butyrate and another (3) higher propionate concentrations in the morning after 
meals rich in non-digestible carbohydrates, whereas one study did not find any 
difference compared with the control meal (12).  
The association between plasma SCFA concentrations and insulin sensitivity 
was also observed in an intervention study (12) which supplemented 30 g/d of 
RS to healthy subjects. Four weeks later, insulin sensitivity (euglycemic-
hyperinsulinemic clamp) was improved and plasma acetate and propionate were 
higher after RS supplementation, compared with the control intervention (no RS). 
The inconsistencies in SCFA results could be due to differences in time points of 
sampling and characteristics of the evening meal. In addition, differences in 
analytical methods may play a role as concentrations in the peripheral circulation 
are in the micromolar range and require very sensitive analytical techniques.  
Efforts have also been made to investigate direct effects of SCFAs on 
glucose tolerance and insulin sensitivity by administering them orally or rectally. 
Venter et al (13) showed that glucose tolerance of healthy young women was 
improved after taking 7.5 g/day sodium propionate for 7 wk. Furthermore, it was 
found that fasting glucose concentrations were decreased in obese male Zucker 
(fa/fa) rats which were fed orally (1 g/d) or infused rectally (0.15 g/d) with 
propionate for 19 d (14). In a recent study, butyrate was found to be able to 
improve insulin sensitivity (Homeostasis model assessment for insulin resistance) 
in high fat diet raised mice (15). In that study, oral supplementation of butyrate 
(5% wt/wt in diet) prevented development of insulin resistance and obesity in 
C57BL/6J mice on a high-fat diet. The insulin sensitizing effect of butyrate was 
further supported by the results of an in vitro experiment which showed that 
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butyrate activated adenosine 5’-monophosphate activated protein kinase (AMPK) 
which is related to improved insulin sensitivity (16). In another study, Boillot et al 
(17) administered propionate (78 g/kg diet) to Sprague-Dawley rats for 3 wk. It 
was found that, compared with control rats, plasma glucose was lower whereas 
plasma insulin was the same for rats fed on diet supplemented with propionate. 
However, in this study, whole insulin sensitivity was not changed as measured 
with the euglycemic-hyperinsulinemic clamp. Taken together, there are 
indications that SCFAs can influence insulin sensitivity. The mechanisms remain 
largely unknown, but some hypotheses have been postulated.  
 
Possible mechanisms by which SCFAs might influence 
insulin sensitivity 
 
1. SCFAs and cytokines 
IL 6 and TNF-α are pro-inflammatory cytokines which have been related to the 
development of insulin resistance and type 2 diabetes (18), whereas adiponectin 
and leptin are regarded as protective cytokines (19;20). SCFAs produced by 
colonic fermentation can have a direct effect on epithelial cells of the large 
intestine. After being absorbed, SCFAs are also available for other tissues and 
organs. Receptors for SCFAs, the orphan G protein-coupled receptors GPR41 
and GPR43, have been found in adipose tissue, colon and immune cells (21-23).  
Cytokines can be secreted by various cells and SCFAs have been shown in 
several in vitro studies to be capable of regulating their secretion. Butyrate was 
found to suppress the pro-inflammatory cytokine interleukin 8 in intestinal 
epithelial cells (24;25), and to suppress interleukin 12 and up-regulate interleukin 
10 secretion in monocytes (26). Butyrate has also been shown to decrease pro-
inflammatory cytokine mRNA expression and production in inflamed and non-
inflamed colonic mucosa biopsies as well as in peripheral blood mononuclear 
cells (27). Propionate induced leptin production in human adipocytes and in mice 
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(22). Butyrate and propionate have been shown to inhibit cytokine-induced 
expression of adhesion molecules in endothelial cells (28;29). All three SCFAs 
decreased lipopolysacharide-stimulated TNF-α release from human neutrophils 
(30). 
However, information about effects of SCFAs on cytokine concentrations in 
human studies is scarce. We showed that an evening meal of barley kernels  
prevented the late postprandial rise in the pro-inflammatory cytokines IL 6 and 
TNF-α after an glucose load in the morning (7). Lower IL 6 concentrations have 
also be found by Nilsson et al (4) in the morning after a barley kernel evening 
meal compared with white wheat bread, however no SCFA concentrations were 
measured in this study. In our study higher concentrations of hydrogen in breath 
were observed during the whole study period in the morning after the barley 
kernel evening meal, while higher plasma butyrate concentrations were observed 
only during the first 2 h postprandial. As the suppressive effect on inflammation 
factors was observed during 2 – 4 h postprandial a direct relationship between 
plasma SCFA concentration and this effect can not be established (7). More 
research is needed to confirm the anti-inflammatory properties of SCFAs found in 
in vitro studies.  
 
2. SCFAs and lipid metabolism 
The relationship between high concentrations of plasma free fatty acids (FFA) 
and the development of type 2 diabetes has been well documented (31;32). One 
of the strategies to prevent insulin resistance is to reduce plasma FFA (33). 
Suppressive effects of SCFAs on FFA, therefore, could be a mechanism by 
which SCFAs modulate insulin sensitivity. 
Several studies showed that rectal infusion (34;35) as well as intravenous 
infusion (36;37) of SCFAs suppress FFA concentrations in humans. SCFAs were 
also found to induce lower plasma FFA when SCFAs were administered to 
humans by gastric infusion for 3 h at a rate calculated on the basis of a 
continuous daily fermentation of 30 g dietary fiber, i.e. acetate (12 mmol/h), or 
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propionate (4 mmol/h), or acetate + propionate (12 mmol/h + 4 mmol/h) (38). 
Suppression of plasma FFA concentrations was also shown in overweight 
volunteers after ingestion of 30 g lactulose, a non-digestible carbohydrate (39). 
The involvement of FFA in the effect on glucose tolerance or insulin 
sensitivity in second meal studies, however, is not clear as the results concerning 
FFA concentrations of these studies are inconsistent (2-4;10).  
 
3. Others 
The study of Gao et al (15) gave an indication as to the possible underlying 
mechanisms of the insulin sensitizing effect of butyrate. Cell culture experiments 
to explore the underlying molecular mechanisms of their observation showed the 
potency of butyrate to directly activate among others AMPK. The activation of 
AMPK by pharmacological means previously has been shown to increase 
glucose transport and cell-surface GLUT 4 content in skeletal muscle from 
nondiabetic men (40).   
Propionate ingestion was able to reduce fasting blood glucose in rats (14). It 
was found in isolated rat hepatocytes that 5 mM of propionate increased glucose 
use and reduced glycolysis (41). The effect of SCFAs on blood glucose could 
play a role in keeping or improving the insulin sensitivity in a long term since 
hyperglycemia was related to insulin resistance. 
An association between oxidative stress and insulin resistance has been 
established by many studies as indicated in a recent review paper (42). As 
SCFAs have been shown to suppress oxidative stress (43) this could be one of 
the mechanisms that link SCFAs to insulin sensitivity. 
 
The relevance of the SCFA profile 
 
As described above propionate and butyrate were related in several studies to 
improved glucose tolerance and insulin sensitivity. However, no significant 
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change was found for insulin sensitivity (euglycemic-hyperinsulinic clamp) by 
Alamowitch et al (44) in men who received an ileal infusion of 90 mmol/L of 
SCFAs (3.3 ml/min for 18 h). The infusion contained 60% acetate, 25% 
propionate and 15% butyrate. Also, an ileal infusion (0.01 mmol/kg BW/min of 
SCFAs) containing equal proportion of acetate, propionate and butyrate, for 7 d 
in pigs did not improve glucose tolerance as measured by frequently sampled 
intravenous glucose tolerance tests (45). 
This shows that the effects of infusions of certain mixtures of SCFAs are 
different from that of individual SCFA. As fermentation of non-digestible 
carbohydrates increases the concentration of all SCFA the observed insulin 
sensitizing effect can not be due to a single SCFA but needs to be determined by 
a certain SCFA profile. However, due to the inaccessibility of the large intestine, 
information of SCFA profiles in vivo after consumption of non-digestible 
carbohydrates is not available. The SCFA profiles of different substrates are 
mainly obtained from in vitro incubations with human fecal samples. Several 
authors reported the rate of fermentation and the concentrations of fermentation 
products of various non-digestible carbohydrates (46-50). 
From these studies could be derived that substrates with higher solubility, 
lower molecular weight, small particle size, and which are easy to be broken 
down by digestive enzymes (e.g. pectins, gum arabic, and guar gum) produce 
higher proportion of acetate. In contrast, wheat bran, oat fiber, cellulose and 
resistant starch are substrates with opposite properties. Those have a lower 
fermentation rate and produce higher proportions of butyrate and propionate. 
Evening meals that have been reported to induce glucose tolerance the next 
morning are mainly meals rich in cereal fiber and resistant starch. Information of 
the in vitro incubations thus implies that a SCFA profile with relative high butyrate 
and propionate proportions could be beneficial.  
 
Strategies for manipulation of colonic fermentation  
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Profiles of SCFAs are mainly determined by the type of substrate, the 
composition and activity of the microbiota as well as the small and large intestinal 
transit (51-53). Therefore, targets for manipulation of colonic fermentation are the 
substrate, the microbiota and the transit.  
 
1. Fermentable substrates 
Fermentable substrates can be of exogenous and endogenous origin. The 
endogenous fermentable substrates include about 2-3 g/day of small intestinal 
mucin and 4-6 g/day of pancreatic proteases. Dietary protein and peptides 
contribute 3-9 g/day fermentable substrate. Protein fermentation can account for 
about 17% of the SCFAs found in the caecum and for 38% of the SCFAs in the 
sigmoid/rectum (54). Dietary carbohydrates contribute the largest amount of 
fermentable substrates: 8-18 g/day of non-starch polysaccharides and 8-40 
g/day of RS in Western populations.  
The chemical and physical structure of the substrate and the combination of 
different substrates influence the SCFA profile. In general, substrates with higher 
solubility (55), shorter chain length (56), smaller particle size (57), faster transit 
(58) are fermented faster. From substrates that are faster fermented higher total 
SCFAs and higher proportion of acetate are produced (55) and the fermentation 
mainly occurs in the proximal colon. Substrates that are fermented at a slower 
rate reach the distal colon and higher proportions of butyrate and/or propionate 
are produced.  
The combination of different non-digestible carbohydrates could be a feasible 
manipulation to obtain an optimal SCFA profile. A less fermentable substrate 
may help to shift the fermentable substrate to the distal colon and prolong the 
production of SCFAs. From high amylose cornstarch combined with wheat bran 
more SCFAs were produced and distal colon fermentation was increased (59) in 
rats. When RS was fed in combination with psyllium, the fermentation could be 
delayed to the distal part of the colon (60). The combined use of different 
substrates may increase the SCFA producing effect of the individual substrates. 
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A mixture of long-chain inulin and short-chain-chain fructooligosaccharides 
produced more SCFAs than equal amounts of the individual substrates (56).  
In healthy volunteers, combined intake of RS and wheat bran resulted in 
higher fecal concentration and proportion of butyrate compared to consumption 
of only wheat bran (61). A mixture of gum arabic and cellulose generated more 
butyrate in the rat hindgut than the individual substrates separately (62). Similar 
results were also observed in pigs (63). When pectin and guar were fed to rats 
separately, the fecal butyrate concentration was low and fermentation mainly 
took place in the caecum. When both substrates were fed together, butyrate 
production doubled and the concentration remained high in the distal colon (64).   
Given the combined use of different substrates and the possible modulating 
approach mentioned above, whole grain food emerges as the model food to 
manipulate colonic fermentation in an optimal way. The whole grain food is rich 
in fermentable DF and RS which means higher fermentation potential. It also 
contains non-fermentable DF. The combined DF and RS may result in higher 
butyrate concentration.  
 
2. Composition of microbiota 
The role of prebiotics and probiotics in the regulation of colon microbiota has 
been extensively reviewed elsewhere (65-68). Different substrates could produce 
different metabolites and the same substrate could be fermented by different 
microbiota to different metabolites (65). In spite of the fact that microbiota are an 
important factor to manipulate SCFAs production this paper is mainly focusing on 
the aspect of substrates.  
 
3. Enzyme inhibitors  
Enzyme inhibitors such as α-amylase and α-glucosidase reduce the rate and 
extent of digestion of dietary carbohydrates and thereby increase the 
fermentable amount. Healthy volunteers were given 50 g starch after an 
overnight fast. Addition of an amylase inhibitor, compared to that of a placebo, 
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increased the amount of total carbohydrates that reached the terminal ileum and 
increased breath hydrogen (69). 
The percentage of butyrate produced is lower from RS than from digestible 
starch (70). Further, acarbose also has been shown to increase colonic transit, 
especially that in the ascending and transverse colon (71), which means that the 
distribution of SCFAs in colon can be affected by application of acarbose. If an 
appropriate amount of acarbose is used, it is possible that colonic fermentation is 
increased without impact on other physiological events such as digestion and 
absorption of protein and fat. 
 
4. Transit time 
Both small intestinal and colonic transit can influence the SCFA profiles. The 
small intestinal transit time is inversely related to substrate availability (72-75). 
Faster OCTT implies that more carbohydrates escape the small intestinal 
digestion and more fermentable substrates reach the colon. In one study (73) it 
was seen that loperamide significantly decreased the amount of unabsorbed 
starch, while magnesium citrate significantly increased starch malabsorption 
when a solid meal containing 50 g potato starch was ingested with either 
loperamide or magnesium citrate. It was also shown that metoclopramide (20 mg 
p.o) reduced carbohydrate absorption in man in a dose related manner (72). The 
effect of the increase in starch malabsorption on SCFA profiles, however, was 
not examined. 
In other studies, the change of the amount of the substrate was not only 
related to the amount of SCFAs produced, but also related to the proportion of 
SCFAs. In one study (58), 28 g of wheat bran, senna or loperamide were in turn 
given to healthy subjects for 9 days, the whole gut transit time was significantly 
shortened by wheat bran and senna, and significantly increased by loperamide. 
The total SCFA and butyrate concentrations in stool were significantly increased 
by senna and decreased by loperamide. In another study (75) the ileal effluent 
was fermented after diets with different RS content. The RS recovered from the 
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ileal effluent was inversely related to the small intestine transit time. The high RS 
diet caused a higher SCFA production and a higher molar proportion of butyrate 
compared with the control diet. 
The colon transit time affects the site of fermentation as well as the rate and 
extent of absorption of SCFAs (58). As the residing microbiota is different at 
different sections of the colon, the fermentation products may also be changed 
accordingly (76;77). Colon transit accounts for 90% of the whole gut transit. 
Bacterial growth and metabolism are more efficient at faster transit times. An 
inverse relationship between mean transit time and the production of total SCFAs 
and butyrate was reported (58). 
Substrates can change the colonic transit time, and different substrates have 
different effects. Lactulose (10-20 mL, 3 times per day) significantly accelerated 
transit of ascending colon in healthy subjects, and it also accelerated movement 
through the rest of the colon. When the poorly fermentable fiber ispaghula was 
added to the lactulose (3.5 g, 3 times per day), the acceleration of the proximal 
colon transit was abolished. On the contrary, the readily fermentable gelling 
agent guar gum (5 g, 3 times per day) further accelerated the effect of lactulose 
(78). 
The colonic transit time is influenced by many factors. The ingestion of a meal 
stimulates colonic motility. After a meal, the increased ileal flow to the ceacum 
increases the availability of substrate which implies immediate increased 
fermentation as the caecum is the most active fermentation site. The effect of a 
meal on colonic fermentation through changing the colon transit time might 
depend on the composition of the meal (79). Two meals, which both contained 
4.18 MJ energy from which 60% was either derived from fat or carbohydrates, 
were given to healthy subjects; the carbohydrate-rich meals induced a colonic 
motor response, but the effects were short lasting when compared with that of 
the fat-rich meals. Fat induced motor activity persisted longer than that of the 
carbohydrate meal, but the onset of motor response was slower.  
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Colonic transit was shown to be slower during nocturnal sleep than during 
daytime and awakening increased the transit. Small particles transits faster than 
bigger particles (80).  
There are many additional factors related to gastro-intestinal transit time, 
which are not possible to manipulate but they should be taken into account. 
Gastric emptying, small intestinal transit and colonic transit were delayed in 
women (81;82). Colonic transit was also delayed in old people and people with 
constipation. Small bowel transit is not different between health young women 
and old women, but colonic fermentation was more pronounced in the young as 
reflected by breath hydrogen (83). Women had significantly longer transits than 
men for the whole, right and rectosigmoid colon and near to statistical 
significance for left colon (84).  
 
Discussion and conclusion 
 
Insulin resistance is a key factor for the development of type 2 diabetes, 
cardiovascular diseases and other chronic diseases. People are encouraged to 
increase their intake of non-digestible carbohydrates and to consume low GI 
food (85). Increased dietary carbohydrates intake will possibly also increase the 
amount of substrates for colonic fermentation and consequently SCFA 
production. Dietary recommendation based on not only GI, but also colonic 
fermentation properties might produce maximal beneficial effects.  
The metabolic effect of colonic fermentation is determined by the SCFA 
profile. The maximal beneficial effect and the optimal SCFA profile can not be 
clearly defined. To what extent the peripheral plasma SCFA profile reflects the 
colonic profile is not yet known. Also, the SCFA profile from different animal 
models are different (86) and may be different from that in humans. The 
information about SCFA profiles of different substrates obtained by in vitro 
fermentation may also not reflect the one in vivo. Therefore, although the 
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available data showed that manipulation of colonic fermentation is feasible, the 
effective SCFA profile should be further identified. 
Concerning the prevention of insulin resistance by certain SCFA, some 
evidence is available. The higher butyrate or propionate concentration in plasma 
in the morning after evening meals rich in non-digestible carbohydrates(7) as 
well as the beneficial effects observed after direct administration of those SCFA 
(13-17) point in the same direction. 
In summary, this review indicates that colonic fermentation of non-digestible 
carbohydrates could be an important factor related to the beneficial effect of 
dietary carbohydrates. Manipulation of colonic fermentation through non-
digestible carbohydrates, especial whole grain food or food with properties of 
whole grain could be a feasible approach to improve insulin resistance and 
insulin resistance related diseases. The relation between SCFA profile and 
insulin sensitivity need to be further investigated.  
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Table 1 Short-chain fatty acids profile of fermentable substrates 
Ratio of SCFAs     Total 
SCFAs 
unit of total SCFAs 
Ace Pro  But 
Species  In vitor or 
in vitro 
 
Reference 
Sugar beet fiber  1160  umol/g substrate 93  7  1  human  in  vitro  (47) 
Citrus pectin  6403  umol/g substrate  90  7  3  human  in vitro  (47) 
Oat fiber  369  umol/g substrate  88  12  1  human  in vitro  (47) 
Pectin (sub 1)      umol/110g substrate  84  7  10  human   in vitro  (49) 
Glucose     220  mmol/L  83  7  10  human  in vitro  (87) 
Pectin     48  mmol/L  82  9  10  human  in vitro  (87) 
Pectin     26  mmol/L  81  10  9  human  in vitro  (87) 
Pectin (sub 2)      umol/111g substrate  81  7  12  human   in vitro  (49) 
Apple pectin  6982  umol/g substrate 80  11  8  human  in  vitro  (47) 
Pectin     80  mmol/L  80  9  12  human  in vitro  (87) 
Control     60.07  mmol/g  78  12  10  rat  in vivo  (88) 
CS (sub 4)    597  umol/106g substrate  77  9  13  human   in vitro  (49) 
CB (sub 4)    657  umol/107g substrate  77  15  9  human   in vitro  (49) 
no treatment  11.43  mmol/L  77  13  11  human   in vitro  (60) 
CB (sub 2)    562  umol/103g substrate  75  14  11  human   in vitro  (49) 
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Ratio of SCFAs     Total 
SCFAs 
unit of total SCFAs 
Ace Pro  But 
Species  In vitor or 
in vitro 
 
Reference 
Pectin     153  mmol/L  75  9  16  human  in vitro  (87) 
CB (sub 3)    605  umol/105g substrate  75  16  9  human   in vitro  (49) 
CB (sub 1)    559  umol/101g substrate  74  16  10  human   in vitro  (49) 
Pea fiber    761  umol/g substrate  74  17  9  human  in vitro  (47) 
Pectin     172  mmol/L  74  7  20  human  in vitro  (87) 
Control     38.7  mmol/L  72  16  12  human  in vitro  (75) 
CS (sub 2)    635  umol/102g substrate  72  6  22  human   in vitro  (49) 
Soy fiber     1943  umol/g substrate  71  21  8  human  in vitro  (47) 
Pectin     114  mmol/L  71  12  17  human  in vitro  (55) 
no-fiber    98.8  mmol/L  71  24  5  rat  in vivo  (89) 
Oat bran (sub 2)    umol/117g substrate  68  7  19  human   in vitro  (49) 
CS (sub 3)    680  umol/104g substrate  70  8  22  human   in vitro  (49) 
Potato starch (sub 1)    umol/112g substrate  70  9  19  human   in vitro  (49) 
Glucose     163  mmol/L  67  12  21  human  in vitro  (87) 
CS (sub 1)    747  umol/100g substrate  65  12  23  human   in vitro  (49) 
Lactose     10  mmol/g CHO  69  12  18  human  in vitro  (90) 
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Ratio of SCFAs     Total 
SCFAs 
unit of total SCFAs 
Ace Pro  But 
Species  In vitor or 
in vitro 
 
Reference 
Xylan (sub 1)      umol/114g substrate  67  14  19  human   in vitro  (49) 
Wheat bran  31  mmol/L  63  14  21  human  in vitro  (87) 
Starch (resistant)  85  mmol/L  69  14  17  human  in vitro  (55) 
Wheat bran (sub 1)    umol/118g substrate  67  14  17  human   in vitro  (49) 
Faecal conc.  128  mmol/L  70  15  11  human  in vitro  (87) 
Wheat bran  21  mmol/L  66  15  16  human  in vitro  (87) 
Parboiled rice bran  101  mmol/L  66  16  18  rat  in vivo  (89) 
Williamson oat fiber  0.42  mmol/L  62  17  21  human  in vitro  (91) 
Extruded rice bran  105  mmol/L  67  17  16  rat  in vivo  (89) 
Oat bran (sub 1)    umol/116g substrate  60  17  20  human   in vitro  (49) 
High RS diet  67  mmol/L  66  18  17  human  in vitro  (75) 
Wheat bran (sub 2)    umol/119g substrate  60  18  20  human   in vitro  (49) 
Glucose     90  mmol/L  63  18  17  human  in vitro  (87) 
Glucose     120  mmol/L  61  18  21  human  in vitro  (55) 
Canadian Harvest oat 
fiber 
0.87  mmol/L  60  18  22  human  in vitro  (91) 
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Ratio of SCFAs     Total 
SCFAs 
unit of total SCFAs 
Ace Pro  But 
Species  In vitor or 
in vitro 
 
Reference 
Cellulose     5  mmol/L  65  19  13  human  in vitro  (87) 
Cellulose     23  mmol/L  61  19  16  human  in vitro  (87) 
Starch     2  mmol/g CHO  61  19  19  human  in vitro  (90) 
Soy fiber     5.75  mmol/L  65  19  16  human  in vitro  (91) 
Carboxymethyl cellulose 
(CMCA) 
0.41 mmol/L  68 20  13  human  in  vitro (91) 
Glucose     35  mmol/L  64  20  17  human  in vitro  (87) 
Fiber form (wheat bran)  54  mmol/L  58  20  22  human  in vitro  (55) 
Control     54  mmol/L  57  22  13  human  in vitro  (87) 
Glucose     26  mmol/L  62  22  17  human  in vitro  (87) 
Albumin     161  mmol/L  41  22  20  human  in vitro  (87) 
Gum arabic  8.19  mmol/L  66  23  11  human  in vitro  (91) 
Psyllium     3  mmol/L  70  24  6  human  in vitro  (91) 
Cellulose   6  mmol/L  63  24  11  human  in vitro  (87) 
Cellulose   5  mmol/L  59  24  14  human  in vitro  (87) 
Albumin   119  mmol/L  41  24  19  human  in vitro  (87) 
  81APPENDIX 2.  MANIPULATION OF COLONIC FERMENTATION   
Ratio of SCFAs     Total 
SCFAs 
unit of total SCFAs 
Ace Pro  But 
Species  In vitor or 
in vitro 
 
Reference 
Inolaxol (sterculia)  41  mmol/L  59  24  16  human  in vitro  (55) 
AP40 15.1  mmol/g  64  25  11  rat  in  vivo  (88) 
Methylcellulose  19.6  mmol/L  67  25  8  rat  in vivo  (89) 
Cellulose   36  mmol/L  59  25  16  human  in vitro  (55) 
Control   32  mmol/L  57  25  18  human  in vitro  (55) 
Cellulose   11  mmol/L  47  25  22  human  in vitro  (87) 
Gum arabic  6936  umol/g substrate  66  25  8  human  in vitro  (47) 
Inulin   38.9  mmol/L  60  26  14  human   in vitro  (60) 
Ileostomy effluent   6.7  mmol/g CHO  63  27  10  human  in vitro  (90) 
Albumin   55  mmol/L  35  27  18  human  in vitro  (87) 
GA40  25.28  mmol/g  64  27  9  rat  in vivo  (88) 
Albumin   23  mmol/L  44  28  14  human  in vitro  (87) 
Albumin   34  mmol/L  39  28  16  human  in vitro  (87) 
Barley 130 kDa  36.71  mmol/L  53  28  19  human   in vitro  (60) 
AP20  23.26  mmol/g  65  28  7  rat  in vivo  (88) 
Gum gum 20 kDa  60.9  umol/mL  66  28  5  human  in vitro  (46) 
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Ratio of SCFAs     Total 
SCFAs 
unit of total SCFAs 
Ace Pro  But 
Species  In vitor or 
in vitro 
 
Reference 
Arabic-guar mixture  7404  umol/g substrate 61  29  10  human  in  vitro  (47) 
Ispaghula  28  mmol/L  66  29  7  human  in vitro  (87) 
Arabinogalactan (sub 1)    umol/108g substrate 57  29  12  human in  vitro  (49) 
GA20 21.87  mmol/g  64  29  7  rat  in  vivo  (88) 
Corn bran  646  umol/g substrate  62  29  9  human  in vitro  (47) 
Vi-Siblin(ispaghula)  76  mmol/L  60  29  11  human  in vitro  (55) 
Lunelax(ispaghula) 79  mmol/L  60  29  11  human  in  vitro  (55) 
Oats 230 kDa  32.78  mmol/L  51  30  18  human   in vitro  (60) 
without A  51.1  umol/g wet wt  44  31  24  human  in vivo  (92) 
Ispaghula  14  mmol/L  61  32  8  human  in vitro  (87) 
Barley 243 kDa  38.82  mmol/L  52  33  15  human   in vitro  (60) 
Guar   7.5  mmol/g CHO  55  33  11  human  in vitro  (90) 
Barley 172 kDa  47.46  mmol/L  46  34  20  human   in vitro  (60) 
Oat fiber  159  umol/g substrate  43  35  23  human  in vitro  (47) 
Oats 150 kDa  43.57  mmol/L  52  35  13  human   in vitro  (60) 
Ispaghula  45  mmol/L  58  35  8  human  in vitro  (87) 
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Ratio of SCFAs     Total 
SCFAs 
unit of total SCFAs 
Ace Pro  But 
Species  In vitor or 
in vitro 
 
Reference 
Ispaghula 92  mmol/L 54  35  11  human  in  vitro  (87) 
Arabinogalactan (sub 2)    umol/109g substrate  54  35  11  human   in vitro  (49) 
Ispaghula 63  mmol/L 55  37  9  human  in  vitro  (87) 
Guar gum 1100 kDa  62.8  umol/mL  54  40  6  human  in vitro  (46) 
Guar gum 400 kDa  68.6  umol/mL  49  41  10  human  in vitro  (46) 
Guar gum 15 kDa  47.9  umol/mL  46  44  10  human  in vitro  (46) 
GA80 5.48  mmol/g  36  44  19  rat  in  vivo  (88) 
AB80   6.82  mmol/g  43  53  5  rat  in vivo  (88) 
Rhamnose   9  mmol/g CHO  44  53  2  human  in vitro  (90) 
AP80  6.11  mmol/g  42  54  4  rat  in vivo  (88) 
Coars wheat bran  61.7  mmol/L  53  22  25  rat  in vivo  (89) 
without A  6.8  umol/g wet wt  46  29  25  human  in vivo  (92) 
Wheat bran  125  mmol/L  58  11  28  human  in vitro  (87) 
Xylan (sub 2)    umol/115g substrate  61  9  29  human   in vitro  (49) 
Wheat bran  48  mmol/L  56  13  29  human  in vitro  (87) 
Wheat bran  82  mmol/L  56  11  30  human  in vitro  (87) 
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Ratio of SCFAs     Total 
SCFAs 
unit of total SCFAs 
Ace Pro  But 
Species  In vitor or 
in vitro 
 
Reference 
Potato starch (sub 2)    umol/113g substrate  64  4  31  human   in vitro  (49) 
with A  61.2  umol/g wet wt  45  23  32  human  in vivo  (92) 
Fine wheat bran  56.2  mmol/L  41  25  34  rat  in vivo  (89) 
with A  13.8  umol/g wet wt  44  21  35  human  in vivo  (92) 
A, acarbose; Ace, acetate; AP, gum A. pycnantha; AB, gum A. baileyana; But, butyrate; CB, cabbage fiber; 
CS, corn starch; GA, gum arabic; Pro, propionate; sub, subject; RS, resistant starch; SCFAs, short-chain 
fatty acids.  
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Abstract 
 
Background 
Information about the extent of carbohydrate digestion and fermentation is critical 
to our ability to explore the metabolic effects of carbohydrate fermentation in 
vivo. We used cooked 
13C-labelled barley kernels, which are rich in indigestible 
carbohydrates, to develop a method which makes it possible to distinguish 
between and to assess carbohydrate digestion and fermentation. 
Materials and Methods 
Seventeen volunteers ingested 86 g (dry weight) of cooked naturally 
13C 
enriched barley kernels after an overnight fast. 
13CO2 and H2 in breath samples 
were measured every half hour for 12 h. The data of 
13CO2 in breath before the 
start of the fermentation were used to fit the curve representing the digestion 
phase. The difference between the area under curve (AUC) of the fitted digestion 
curve and the AUC of the observed curve was regarded to represent the 
fermentation part. Different approaches were applied to determine the proportion 
of the 
13C-dose available for digestion and fermentation. 
Results 
Four h after intake of barley, H2-excretion in breath started to rise. Within 12 h, 
24-48% of the 
13C-dose was recovered as 
13CO2, of which 18-19% was derived 
from colonic fermentation and the rest from digestion. By extrapolating the curve 
to baseline, it was estimated that eventually 24-25% of the total available 
13C in 
barley would be derived from colon fermentation.  
Conclusion 
Curve fitting, using 
13CO2- and H2- breath data, is a feasible and non-invasive 
method to assess carbohydrate digestion and fermentation after consumption of 
13C enriched starchy food. 
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Introduction 
 
Food components that escape small intestinal digestion can be fermented in the 
colon. Dietary carbohydrates, specifically resistant starch (RS) and soluble 
dietary fiber (SDF), are potential substrates for fermentation. Accumulating 
evidence indicates that fermentation is related to many physiological effects 
through the production of short-chain fatty acids as metabolically active signalling 
agents (1;2). In some studies, colonic microbial activity has also been linked to 
the development of obesity (3;4). However, colon fermentation is a complex 
process which is determined by a cluster of factors including substrate 
properties, microbiota profile and activity as well as intestinal transit time and 
absorption capacity of the colonic epithelial cells. Both the digestive phase and 
the fermentative phase are related to nutrient bio-availability. In order to analyse 
the contribution of the digestive as well as of the fermentative phase to the 
overall biological effects of starchy food, we need to know the extent of digestion 
and fermentation of the specific carbohydrates.  
Various methods have been developed to measure carbohydrate digestion 
and fermentation including the H2-breath test, ileostomy and intubation of the 
ileum. However, the H2-breath test is dependent on the composition of the 
colonic microbiota and the type of fiber (5), and is only semiquantitative (6). 
Radioscopy may be harmful, and in the case of ileostomy and intubation 
disturbed intestinal functions are likely (7).  
The 
13CO2-breath test can be used to quantitatively monitor digestion of 
13C-
labelled starch because a considerable portion of digested carbohydrate is 
oxidised (8). However, after the arrival of indigestible carbohydrates in the colon, 
both small intestinal digestion and colonic fermentation are contributing to breath 
13CO2. Previous studies have attempted to measure the extent of starch 
digestion and fermentation by mathematic modelling in infants (9) and adults (10) 
using 
13CO2 data only. As the increase of breath H2 indicates the arrival and 
fermentation of indigestible carbohydrates in the colon (11), a combination of the 
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two tests seems useful for a non-invasive approach (12) and improved 
modelling. Our aim was to develop a curve fitting approach for the estimation of 
the extent of carbohydrate digestion and fermentation by applying a combined 
13CO2- and H2-breath test. 
 
Subjects and methods 
 
Subjects 
Seventeen healthy volunteers (7 male, 10 female) aged 20.9±0.3 (Mean±SEM)   
years, with a Body Mass Index of 21.1±0.4 (kg/m
2) took part in the study. The 
criteria for exclusion were current use of any medications, use of antibiotics in 
the last 3 months, gastrointestinal symptoms, diabetes mellitus and 
gastrointestinal surgery. Written informed consent was obtained from all 
subjects. Approval was obtained from the Medical Ethics Committee of the 
University Medical Centre in Groningen. 
 
Test meal 
Spring barley (var Kirsty) was grown in 20 cm pots in a greenhouse. Upon 
anthesis, pots were moved to 600 L growth cabinets (Fitotron; Fisons UK) which 
had been sealed from the atmosphere.  Approximately 1 L 
13CO2 (Spectra 
Gases, NJ, USA) was added to each growth cabinet.  After 24 h incubation, pots 
were returned to the greenhouse until harvest. The 
13C abundance of the barley 
was determined by isotope-ratio mass spectrometry to be 1.128 atom % 
13C. 
Percentage carbon was also estimated by this technique to be 39.6%. Eighty six 
gram of barley (estimated amount available carbohydrate (AC), RS and SDF: 50 
g, 7.5 g, 4.4 g respectively (13) )were cooked in 250 ml water with 1 g salt till all 
water was absorbed (35 min). 
 
Study protocol 
  99 
APPENDIX 3.  ESTIMATION OF FERMENTATION 
 
The subjects were asked to refrain from alcohol and strenuous exercise for 24 h 
before each study day. At 8:00, after an overnight fast, volunteers consumed the 
test meal within 30 min with 250 mL of water. Breath samples were collected by 
breathing through a straw into 10-mL tubes. Three breath samples were 
obtained before consumption of the test meal and thereafter every half hour for 
12 h. A standard lunch, consisting of two white bread rolls with ham or cheese, 
was provided to the subjects 4 h after intake of the test meal. All the subjects 
were dismissed after 2 h when normal daily activities were resumed, except that 
volunteers were asked neither to engage in intensive physical exercise, nor to 
consume 
13C enriched food and to take their dinner 9 h after the intake of the test 
meal.   
 
Analytical procedures 
Analysis of 
13C abundance in breath CO2 was performed using gas 
chromatography isotope ratio mass spectrometry (GC/IRMS) (TracerMAT, 
Thermo Finnigan, Bremen, Germany) measuring the 
13C/
12C ratio versus the 
international standard Pee Dee Belemnite (δ
13CPDB) in ‰. Breath H2 was 
measured using gas chromatography with a thermal conductivity detector (HP 
6890 Agilent, Hewlett Packard Co, Palo Alto, USA), using a CP-Molsieve 5A 
column of 25 m×0.53 mm (50 μm film thickness) (Chrompack International B.V., 
Bergen op Zoom, The Netherlands). 
 
Calculations and curve fitting 
Physical activity level (PAL) is a parameter to express the energy expenditure 
level based on a person’s physical activity. During the first 6 h the volunteers 
were sitting and we estimated a PAL of 1.0. The last 6 h the volunteers could go 
home and we assumed light activity in this phase which means that the PAL will 
be about 1.2 times that of the PAL during the first 6 h  (14;15). As it was also 
suggested that energy expenditure for adults under experimental situations 
similar to that of the first 6 h in this study were above resting and PAL would be 
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1.3 instead of 1.0 (16), we also used a PAL of 1.3 and 1.56  for the rest and 
active period respectively for our calculations. CO2 production was assumed to 
be 300 mmol/m
2 body surface area (BSA) per hour at rest (17). BSA was 
calculated according to the classic weight-height formula of Haycock et al (18). 
Resting CO2 production was multiplied by PAL to give total CO2 production.  
The 
13CO2 excretion in breath was expressed as percentage of the 
administered dose per hour (%dose/h) and as a cumulative percentage of the 
administered dose (cum %dose) over time. The following approaches were used 
to define the administered 
13C-dose: 
 
1.  Percentage carbon-atoms present in the sample (C%) 
The percentage of carbon-atoms in the barley samples was measured to 
be 39.6% which was used for the calculation of the dose (2.84 moles 
carbon).  
2.  Dose of available carbohydrate (ACHO) 
As the barley meals contained 50 g available carbohydrate this amount 
was used to calculate the 
13C-dose (1.85 moles carbon). 
3.  Dose of total carbohydrates available for digestion and fermentation 
(TCHO) 
13C dose was calculated based on the total amount of available 
carbohydrates in the test meal, thus digestible carbohydrate, RS and 
SDF. This was estimated to be 61.9 g (2.29 moles carbon). 
 
The H2 results were expressed as parts per million (ppm). A sustained 
increase in H2 of more than 10 ppm was regarded to indicate the arrival of 
carbohydrates in the colon (19). We regarded the time point before this increase 
as starting point of fermentation. Time from intake of test meal to this point was 
regarded as the oro-cecal transit time (OCTT). 
The data of the %dose/h were used to fit a curve with the equation (20): y = a 
× (t + d)
b × e 
-c × (t + d). In the equation, y is the %dose/h; t is time; a, b, c and d are 
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constants.  The curve was fitted with Solver of Microsoft Excel 2003. In principle, 
initial values of constants a,  b,  c and d were specified based on previous 
experience and then optimized  by minimizing the value of the squared sum of 
the difference between data and fit. Breath 
13CO2 data before the time point of 
start of fermentation were used to fit the curve representing the digestion phase. 
The areas under the curves (AUC) were calculated for the observed and fitted 
curves. The difference between both AUCs resulted in the fermentation curve.  
The 12 h 
13CO2 data were used to fit a curve to baseline describing eventual total 
13CO2 appearance. Curves were fitted separately for all the 17 subjects and the 
average values calculated.   
It was assumed that the recovered part of 
13C represents the fate of all the 
available 
13C in the test meal and that protein and fat present in the test meal are 
digested completely in the small intestine. Food tables state that pearled raw 
barley grain contains 77% carbohydrate, 10% protein and 1% fat (21). Using 
accepted stoichiometry, this gives a theoretical content of 41% carbon or 3 moles 
carbon per 86 g.  Also, we assumed that the colon is the main source of breath 
H2 and colonic H2 will be excreted in breath immediately after production (11). 
 
Results 
 
Hydrogen  
H2 in breath increased significantly at 252 ± 15 min after intake of the test meal 
and remained at least 10 ppm above baseline level during the whole study 
period (Figure 1).  
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Figure 1 Mean ( SEM) of breath H2 in 17 healthy subjects after ingestion of 86 
g (dry weight) intrinsically 
13C-labelled barley kernels. 
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After intake of the test meal, breath 
13CO2 increased steadily and 12 h after 
intake of the test meal, 29.9% of the administrated 
13C was recovered (Figure 2). 
Data for Figure 2, 3 and 4 were calculated based on values of PAL 1.0 (first 6 h) 
and 1.2 (last 6 h) and TCHO as 
13C-dose. 
 
Curve fitting and calculations 
Figure 3 shows the course of the fitted curve for the digestion phase and for the 
fermentation phase. This fermentation curve was obtained by subtracting fitted 
digestion data from the observed data, whereas the fermentation curve shown in 
Figure 4 was obtained by subtracting the fitted digestion data from the fitted total 
data.  Figure 4 depicts the mean values and SEM of cum%dose, fitted total 
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curve, fitted digestion curve and fermentation curve. All these curves were 
extrapolated to a time of 24 h after intake of the test meal. About 24 h after the 
intake of the test meal, breath 
13CO2 has returned to baseline. Furthermore, the 
predicted cum%dose reaches a plateau value 18 h after intake of the test meal 
(Figure 4).  
The results based on different definitions of the administered 
13C-dose and 
PALs were shown in Table 1.  The cum%dose over 12 h lay between 23 and 
48%. From that 18-19 % accounted for fermentation and it was estimated, based 
on the exploration of the curves to baseline, that eventually 24-25 % of the total 
cum%dose after 24 h would be derived from fermentation. 
 
 
Figure 2 
13CO2 excretion in breath as mean ( SEM) percentage of administered 
dose per hour and mean ( SEM) cumulative percentage of the administered 
dose, in 17 healthy subjects after ingestion of 86 g (dry weight) intrinsically 
13C-
labelled barley kernels. 
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Figure 3 Digestive and fermentation curves fitted with data of mean percentage 
of the administered dose per hour in breath samples of 17 healthy subjects after 
ingestion of 86 g (dry weight) intrinsically 
13C-labelled barley kernels. 
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Figure 4 Extrapolated total curve, digestion curve, fermentation curve and 
cum%dose curve for the mean ( SEM) of 17 healthy subjects after ingestion of 
86 g (dry weight) intrinsically 
13C-labelled barley kernels. Data after 720 min were 
extrapolated.  
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Table1. Results calculation the cumulative percentage of the administered dose 
using different approaches 
1 
13C-dose calculated from   
PAL
2 (1
st 6-
h – 2
nd 6-h) 
 
ACHO
3  TCHO
4  C%
5 
total (cum%dose  
after 12h) 
37.0 ± 1.6  29.9 ± 1.3  23.4 ± 1.0 
% fermentation  from 
total (12 h) 
19.0 ± 2.2  18.2 ± 2.4  18.0 ± 2.5 
 
1.0 – 1.2 
% fermentation 
from predicted total 
(extrapolated to 24 h) 
24.8 ± 3.0  23.8 ± 3.2  25.1 ± 3.2 
total (cum%dose 
 after 12h) 
48.1 ± 2.1  38.9 ± 1.7  30.4 ± 1.3 
% fermentation  from 
total (12 h) 
18.7 ± 2.0  18.9±2.2  18.6±2.1 
 
1.3 – 1.56 
 
% fermentation 
from predicted total 
(extrapolated 24 h) 
25.4 ± 2.6  25.0 ± 3.0  24.6 ± 2.7 
1 Results are expressed as mean ± SEM. 
2 PAL: physical activity level. 
3 ACHO: dose of available carbohydrate. 
4 TCHO: dose of total carbohydrates available for digestion and fermentation. 
5 C%: percentage carbon-atoms present in the sample. 
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Discussion 
 
Stable isotope breath tests have proven to be a safe, simple and non-invasive 
method to investigate gastrointestinal function and metabolism. Oxidation of 
13C-
labelled carbohydrate following digestion and fermentation can be evaluated by 
measuring 
13CO2 excretion in the breath (22). With mathematical models, it is 
possible to distinguish between 
13CO2 produced by small intestine digestion and 
that by colonic fermentation (9;10;20). By combining breath H2 and 
13CO2 
measurements with a curve fitting approach we were able to quantitatively 
assess the digestion and fermentation of carbohydrates in a starchy food. 
Depending on the different approaches used to estimate the 
13C-dose and the 
PAL the cum%dose recovered varied between 23 and 48 %. From this dose 
recovered it appeared that 18-19 % was due to the colonic fermentation of 
carbohydrates, which was estimated to increase to 24-25 % if measurement 
would have been extended to 24 h. (Table 1). Only one study could be found 
using a similar approach in two adults. This study reported a cum%dose 
recovered of 28% in one subject and 40 % in the other subject after consumption 
of 
13C-enriched pea flour over a time period of 18 h (10). Although these data are 
similar to ours, the difference in test meals and study design and duration makes 
direct comparison difficult.  
In this study we explored the impact of different estimations of CO2 output on 
the study results. In addition, different approaches to calculate the 
13C dose that 
can theoretically be recovered in breath CO2 were used. Our data show that 
those variations only influence the total cum%dose. The proportion derived from 
fermentation remained in a narrow range for both the 12 h measurement and the 
extrapolated 24 h estimate. Thus, it can be concluded that the calculation of the 
relative contribution of fermentation is robust across different approaches for the 
calculation of the total cum%dose and CO2 output. Direct measurement of CO2 
output in future studies would help to constrain this variable (16). 
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Concerning the calculation of the 
13C dose we acknowledge that there was 
also about 10% labelled protein present in the test meal, which could have 
influenced our results. Given that protein will largely be digested and possibly 
only a third of the assimilated amino acids would be oxidised during the study 
(23;24), we would expect a minor contribution from protein to the 
13CO2 
production during digestion and very little more during the fermentation phase. 
The combination of the 
13CO2- and H2 breath test has been proven to be of great 
value. After consumption of the labelled barley kernels an immediate rise in 
13CO2 was seen, which did not return to baseline during the study period.. From 
this curve the start of the fermentation could not be derived because the 
contribution of fermentation was apparently not late enough or high enough to 
result in a discrete second peak. This observation is different to that of a study 
which observed a distinct second rise in 
13CO2 excretion starting 432 ± 15 min 
after ingestion of 40 g resistant cornstarch (12). Therefore, in studies using 
common food products, which normally have a lower content of indigestible 
carbohydrates, measurement of breath H2 may be necessary to apply curve 
fitting. Breath H2 excretion started at 252 ± 15 min and showed surprisingly little 
variation between subjects. This might be due to the fact that subjects received a 
subsequent meal 240 min after intake of the test meal. Because the intake of a 
meal stimulates the movement of the intestine, indigestible material is moved 
distally and increases fermentation (11). Our previous studies showed that a 
subsequent meal may influence the OCTT of a liquid test meal (25), but not a 
solid test meal (26). The discrepancy between our studies may lay in the 
difference of presence of indigestible solids as caloric content of the test meals 
was similar (330 kcal previous, 300 kcal present). McIntrey et al (27) observed a 
pronounced OCTT acceleration of 95 min after addition of bran (2-5 mm particle 
size) to the rice porridge test meal. This suggests that indigestible solids present 
in barley could be the cause of the rapid OCTT, with the subsequent meal 
causing their movement distally.   
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In summary, curve fitting using data from measurements of 
13CO2 and H2 in 
breath samples could be a feasible, objective and non-invasive method to 
quantitatively assess digestion and fermentation of different starchy food. In 
addition, with this approach, it would be possible to examine individual 
differences in recovery of energy from colon after starchy food consumption, 
through simultaneous estimation of short chain fatty acid production (28). As it 
has been shown that the number of bacteria with the capability to break down 
indigestible dietary carbohydrates is positively related to obesity (3;4), 
 this could 
facilitate investigating the relationship between the degree of colonic 
fermentation and the development of obesity.  
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Abstract 
 
Health effects of whole grain foods are becoming more evident. In this study, we 
analyzed the colonic fermentation process of 
13C barley meals, prepared from 
barley grown under 
13CO2-atmosphere. In a cross over study 5 volunteers 
ingested intact barley kernels (high content of dietary fiber and resistant starch) 
and barley porridge (high content of dietary fiber only). Using a newly developed 
stable isotope technology we monitored 14 h postprandially 
13C-acetate, 
13C-
propionate and 
13C-butyrate in plasma and urine. The oral-cecal transit time of 
the meals was measured with the hydrogen breath test and the 
14CO2-inulin test. 
The oro-cecal transit time was 6 h and did not differ between the two test meals. 
An increase of 
13C-acetate was observed already early after ingestion of the 
meals (< 6 h) and was attributed to early fermentation of the test meal. A rise in 
13C-propionate in the fermentation phase could only be detected after the 
porridge and not after the kernels meal. An increase in 
13C-butyrate was only 
found in the fermentation phase and was higher after the barley kernels. Urine 
13C-short chain fatty acids data were consistent with these observations. In 
conclusion: The difference in the profiles of 
13C-acetate, 
13C-propionate and 
13C-
butyrate indicates that dietary fiber combined with resistant starch results in an 
altered fermentation profile than dietary fiber alone. 
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Introduction 
 
Whole grain foods have been associated in epidemiological studies with the 
prevention of cardiovascular disease, obesity and type 2 diabetes (1-3). One of 
the characteristics of whole grain foods is their relatively high content of resistant 
starch (RS), if unprocessed (4), and of non-starch polysaccharides (NSP). These 
components were related in intervention studies to improved insulin sensitivity (5-
8) and glucose tolerance (9-11). Furthermore, effects on lipid metabolism in 
adipocytes (12;13) and postprandial lipid oxidation (14) are reported. However, 
the exact mechanism underlying these processes is not clear. It is likely that 
those effects of NSP and RS are mediated through fermentation of RS and NSP 
in the colon which results in the production of the short-chain fatty acids (SCFA) 
acetate, propionate and butyrate. There is emerging evidence that SCFA not 
only exert effects in the colonic epithelial cells but also enter the circulation and 
can influence metabolic processes in other tissues and organs. Effects of acetate 
and propionate on glucose and lipid metabolism in the liver have been reported 
(15-20). Acetate is used in the liver as substrate for the synthesis of cholesterol 
and fatty acids whereas it seems that propionate inhibits these processes (21). 
Effects of SCFA on adipose tissue metabolism are likely as SCFA have been 
identified to be ligands for the orphan G protein-coupled receptor GPR41 which 
is primarily expressed in adipose tissue (22) and stimulation of leptin production 
in adipocytes by propionate (not acetate) has been described (23). Since 
adipose tissue is known to secrete various signalling peptides influencing among 
others insulin sensitivity, feeding behaviour and inflammation (24) it could 
constitute an important link between SCFA production and peripheral metabolic 
effects. Furthermore, a possible importance of products of colonic fermentation in 
the aetiology of obesity has recently emerged in a study that showed that 
microbiota of obese mice was more capable of fermenting non-digestible dietary 
polysaccharides which consequently extracted more calories from the food than 
the microbiota of lean mice (25). 
  116 
APPENDIX 4.  TYPE OF CARBOHYDRATES AND SCFA PROFILES 
 
To be able to investigate the interaction between colonic SCFA production 
and peripheral tissue it is necessary to obtain information about the extent to 
which fermentation derived SCFA reach systemic circulation. Furthermore, as 
different SCFA can exert different and even opposing effects, information is 
needed as to how different fermentable substrates affect these SCFA patterns in 
the circulation.  
Recently, we developed new analytical methods to determine low-level 
enrichment of 
13C-SCFA in human plasma and urine (26). These methods were 
applied to test the hypothesis that ingestion of a test meal with a high content of 
NSP results in a different 
13C-SCFA plasma profile than a test meal that in 
addition contains RS. 
13C-enriched barley was obtained by culturing plants under 
13CO2 enriched atmosphere for the test meals. The test meals administered were 
intact cooked barley kernels (high RS and NSP) and barley porridge (high NSP). 
 
Materials and methods 
 
Subjects 
Five healthy volunteers with a mean age of 25 ± 7 y participated in the study. 
None of the subjects had a history of gastrointestinal or metabolic disease or 
previous surgery (except for appendectomy). The subjects were free of 
antibiotics or any other medical treatment influencing gut transit or intestinal 
microbiota for at least 3 mo before the start of the study. The study protocol 
complied with the Helsinki Declaration and was approved by the Ethics 
Committee of the University of Leuven. All subjects gave written informed 
consent. Each of the subjects performed two tests, respectively with barley 
porridge and barley kernels as test meal. 
 
Study design 
After an overnight fast, the volunteers presented in the morning at the laboratory 
where they were asked to provide a basal urine sample and three breath 
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samples for measurement of respectively H2, 
13CO2 and 
14CO2. In both arms, a 
catheter was introduced in an antecubital vein and a basal blood sample was 
withdrawn. Consequently, the volunteers received a test meal prepared from 
13C-
labelled barley to which 74 kBq inulin-
14C-carboxylic acid (Amersham 
Biosciences, Uppsala, Sweden) (27) had been added as well as a glass of water. 
The test meal was always consumed within 20 min. Blood samples were 
collected from the contralateral arm every hour during the first 5 h, every 20 min 
from 5 to 8 h and every 40 min from 8 up to 14 h. Breath samples were collected 
every 20 min up to 6 h for analysis of 
13CO2 and up to 10 h for analysis of H2 and 
14CO2. Three volunteers collected all urine for 24 h in different fractions using 
specified receptacles to which neomycin was added for prevention of bacterial 
growth. After 6 h, 9 h and 12 h, a standard, light and non-fermentable meal was 
offered to the volunteers (sandwich with ham or cheese). Unlimited access to 
water was allowed from 6 h after the start of the infusion. 
 
Test meals 
Production of labelled barley 
Barley, Hordeum vulgare Var. Kirsty, was sown in 20 cm diameter pots each 
containing 9 seeds. A proprietary growing medium was used (Shamrock Potting 
Professional, Scotts, Ireland). The plants were grown in a greenhouse for 
approximately 6 wk until anthesis, which was determined visually. For labelling 
with 
13CO2, plants were moved in batches into a gas-tight 600 L growth cabinet 
(Fisons Fi-totron) which was operated at 18 
oC, with 16 h light per 24 h. The 
cabinet contained a maximum of 18 pots. 
13CO2 additions of 600 mL were made 
from a gas cylinder (99 atom % 
13C; Spectra Gases, NJ, USA) by transfer from a 
fixed volume at known pressure. The plants were incubated for 4 d and then 
returned to the greenhouse until harvesting approximately 3 mo later. The grain 
was prepared and separated using a single ear thresher. Sub-samples of grain 
were ground into fine flour. 
13C abundance and carbon content was measured by 
continuous-flow isotope ratio mass spectrometry (28). 
13C-enrichment was 
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calculated after subtracting the abundance of unlabelled grain grown under the 
same conditions. Two batches of barley were produced. The first batch weighed 
165 g and its 
13C enrichment was 1.852 atom % 
13C excess. The second batch 
weighed 171 g and its 
13C enrichment was 2.985 atom % 
13C excess. The 
average carbon content was 39.6 %. 
 
Pearling/milling barley 
A barley pearling machine was used to remove the outer hull of the barley 
kernels. By this procedure the original weight of the barley kernels was reduced 
by 15 %. For the porridge, barley kernels were milled in an electric household 
grain mill (SAMAP Elsässer grain mill F 100) on the finest grade. 
 
Preparation and composition of test meals 
Barley porridge was prepared by addition of about 86 g of flour to 150 mL water 
and gently blending to remove lumps. Thereafter, 300 mL additional water was 
added along with 1 g of NaCl after which this portion was cooked in a microwave 
oven for 5 min at 600 W.  
For the barley kernel test meal about 86 g of barley kernels were boiled at low 
temperature in 320  mL of water until all water was absorbed by the kernels 
(approximately 40 min).  
 
Analytical procedures 
Analysis of breath samples 
For 
13CO2 and hydrogen measurements, breath was collected in exetainers 
(PDZ, Cheshire, UK). The 
13C-breath content was determined by isotope ratio 
mass spectrometry (ABCA, PDZ, Cheshire, UK). We assumed CO2-production to 
be 300 mmol/m² body surface area per hour (29). The body surface area was 
calculated by the weight-height formula of Haycock et al (30). The results for 
digestion of barley were expressed as the cumulative percentage of administered 
dose of 
13C excreted over 6 h, the maximal excretion rate of 
13C and the time to 
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maximal excretion rate of 
13C. The amount of administered dose of 
13C was 
calculated taking into account the known enrichment of the labelled barley and 
the fact that an 86-g portion of barley contains 56 g of total starch.  
Hydrogen was measured in an H2-monitor (MEC, Brussels, Belgium) which 
contained an electrochemical cell and yielded a digital read out of hydrogen 
concentration in parts per million (ppm).  
Breath samples for measurement of 
14CO2 were collected by blowing through 
a pipette into a vial containing 2 mmol of hyamine hydroxide until discoloration of 
the thymolphtaleine indicator, corresponding to the capture of 2 mmol of CO2. 
14CO2 was measured by liquid scintillation counting (Packard Tricarb Liquid 
Scintillation Spectrometer, model 3375, Packard Instruments Inc., Downers 
Grove, IL, USA) after addition of 10 ml of Hionic fluor (Perkin Elmer, Boston, 
USA). Orocecal transit time (OCTT, i.e. the time that elapses between intake of a 
meal and arrival of the meal in the colon) was calculated on the basis of 
14CO2 
and H2-excretion and was defined as the time at which a significant increase in 
14C and H2 from the background was seen, i.e. 2.5 times the standard deviation 
of all previous points above the running average of all previous points (31).  
 
Analysis of SCFA concentrations in plasma samples 
Concentrations of SCFA were determined as previously described (32). Briefly, 
plasma samples (500 µl) were deproteinised with sulfosalicylic acid after addition 
of 3-methylvalerate as an internal standard. The supernatant fraction was 
extracted with 3 ml diethyl ether and tert-butyl-dimethyl-silyl-imidazole was added 
to the organic phase. The reaction mixture was heated at 60°C for 30  min, 
cooled and evaporated to approximately 500 µl. SCFA derivatives were analysed 
on a GC/MS (Hewlett Packard, Palo Alto, CA, USA) using positive chemical 
ionisation. 
 
Analysis of 
13C-enrichment in plasma samples 
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After addition of 200 µL of NaCl (4M) (99.8% purity, Sigma-Aldrich) to 1 mL of 
plasma, proteins were removed by centrifugation at 4575 g for 2 h 40 min using 
Amicon centrifugal filter devices YM-30 (Millipore, Bedford, MA, USA). Plasma 
ultrafiltrates were concentrated to 200 µL under a nitrogen stream and acidified 
to pH 2.5-3 by adding 10 µL of HCl (2 M).  
SPME fiber (CAR/PDMS from Supelco (Bellefonte, PA, USA)) was exposed 
to the analytes by immersion in the sample at 40 °C for 45 min. The SCFAs 
adsorbed on the SPME fiber were injected by direct desorption into a gas 
chromatography (HP 5890, Hewlett Packard, Palo Alto, CA, USA). The 
13C-
SCFA analysis was performed using a gas chromatography - combustion - 
isotope ratio mass spectrometry (GC/C/IRMS) (Delta S, Finnigan MAT, Bremen, 
Germany) (25). 
 
Calculation of the enrichment of 
13C-SCFA 
The data were obtained using the formula: 
￿
13C(‰) = [(
13C/
12Csample - 
13C/
12CVPDB)/
 13C/
12CVPDB]*1000 
(where 
13C/
12CVPDB = 0.0112372),  
therefore: 
13C/
12Csample = 
13C/
12CVPDB *
 [1+0.001* ￿
13C] 
The observed abundance of 
13C in a sample, given in Atom Percent (AP) is 
defined as: 
  AP  =  100*
13C/
12CVPDB[(0.001￿
13Csample)+1] 
The isotopic enrichment in a sample as compared to a standard value (basal 
value) is given in Atom Percent Excess (APE): 
APE = APsample – APbasal value  
Finally, plasma concentrations of 
13C-SCFA were calculated by multiplying the 
APE of the respective SCFA with its plasma concentration. 
 
Analysis of urine samples 
Urine samples were stored at -20 
oC until analysis. SCFA were extracted from 
2.5 mL samples following ultrafiltration to remove high molecular weight 
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compounds and solid phase extraction to concentrate and purify samples. 
Samples were stored dry with excess alkali. They were acidified and back 
extracted into ether prior to analysis. Concentration analysis and standardisation 
of 
13C abundance were achieved by use of a 3-methyl valerate internal standard 
(33). 
13C abundance was measured by GC-C-IRMS and 
13C enrichment of 
urinary SCFA was calculated as above. SCFAs were measured by GC/MS as 
described by Morrison et al (33). 
 
In vitro analyses of starch fractions 
An adapted version of the method described by Englyst (34) was used to 
analyse the starch fractions in the test meals. In short, samples were 
disintegrated, if necessary, in order to mimic chewing and incubated with pepsin-
HCL. After adjustment of the pH, samples were incubated with pancreatin and 
microbial amyloglucosidase for 2 h. Samples were taken after 20 and 120 min of 
incubation time. The amount of glucose present after 20 min of incubation 
presented the rapidly available glucose fraction. After 120 min total digestible 
glucose was measured (G120). The amount produced between 20 and 120 min 
of incubation presented the slowly available glucose fraction. After 120 min the 
samples were treated with sodium hydroxide in order to solubilise resistant 
starch. This resistant starch was converted quantitatively into glucose and total 
glucose (TG) was measured. The resistant starch fraction was calculated by 
subtracting G120 from TG and by multiplying the result by 0.9.  
 
Statistical analysis 
Results are expressed as mean values and standard deviations. Non-parametric 
statistical evaluation (Wilcoxon test and Mann-Witney test) was performed using 
SPSS software (SPSS 15.0 for Windows; SPSS Inc., Chicago, IL, USA). The 
level for statistical significance was set at P < 0.05. Differences for which P-
values were <0.1 were considered as tendencies. 
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Results 
 
In vitro analysis of starch fractions 
Total starch content and starch fractions of the test meals were analysed in vitro. 
The total starch content in the barley meals was 56 g. The percentages of rapidly 
available glucose, slowly available glucose and resistant starch of total starch in 
the barley kernels and barley porridge were 62, 34, 4 and 98, 2, 0 respectively. 
Soluble fiber content of barley is reported to lay between 8 and 14 % (dry weight) 
(35).  
 
OCTT 
OCTT was calculated on the basis of both an increase in H2-excretion, as an 
indication of fermentation of the administered barley, and an increase in 
14CO2-
excretion, indicating hydrolysis of the tracer inulin-
14C-carboxylic acid added to 
the test meal. Figure 1 shows a representative example of the excretion of H2 
and 
14CO2 obtained after administration of a barley porridge meal to a volunteer. 
Although OCTT values obtained on the basis of H2-excretion were statistically 
significantly shorter than values obtained on the basis of 
14CO2 measurements (P 
= 0.023), the mean difference between both measurements was only 20  min 
which corresponds to one sampling interval. Hence, this difference was not taken 
into account. 
No statistically significant differences were observed in OCTT values of 
barley porridge (360 ± 47 min for H2-measurements and 365 ± 55 min for 
14CO2-
measurements) as compared to barley kernels (372 ± 18 min for H2-
measurements and 400 ± 0min for 
14CO2-measurements)(P  = 0.705 for H2-
measurements and P = 0.285 for 
14CO2-measurements). 
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Figure 1 Representative example of H2-excretion and 
14CO2-excretion obtained 
after administration of a barley porridge test meal, to which 74 kBq 
inulin-
14C-carboxylic acid had been added 
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Digestion of administered 
13C-barley 
The parameters reflecting the extent of digestion of the 
13C-barley test meals are 
presented in Table 1. The cumulative 
13C-excretion as well as the peak excretion 
were not significantly different for 
13C-barley porridge and for 
13C-barley kernels, 
suggesting no difference in terms of the ultimate quantity of tracer oxidised 
between the porridge meal and the kernel meal. The time to maximal 
13C-
excretion was significantly shorter for the porridge meal (P = 0.043) indicating a 
faster digestion than that of the kernel meal. 
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Table 1 Small intestinal digestion of administered 
13C-barley meals (mean ± sd) 
 
13C-barley porridge 
13C-barley kernels 
Cum 
13C-excretion 
(% of administered dose) 
 
33.9 ± 19.5 
 
26.7 ± 15.1 
peak excretion of 
13C 
(% of administered 
dose/h) 
 
7.9 ± 4.9 
 
6.3 ± 3.6 
time to peak excretion of 
13C (min) 
 
200 ± 32 
 
300 ± 42* 
* significantly different from barley porridge (P < 0.05) 
 
13C-SCFA concentrations in plasma 
The plasma concentration of 
13C-SCFA, the main products from colonic 
fermentation of administered 
13C-barley are presented in Figure 2.  
After administration of both test meals, an increase in 
13C-acetate was 
already observed in the early phase (< 360 min) (Figure 2, A). A second peak in 
13C-acetate enrichment was observed in the later phase (> 360 min) and was 
higher after the barley kernels test meal than after the barley porridge test meal. 
The area under the curve (AUC) tended to be higher after barley kernels. 
However, the difference did not reach statistical significance (P=0.064). A rise in 
13C-propionate enrichment was detected after the barley porridge meal for only 3 
volunteers but never in the plasma after the barley kernels meal (Figure 2, B). An 
increase of 
13C-butyrate enrichments was only found in the fermentation phase 
and was comparable after the barley kernels and barley porridge meal (Figure 2, 
C). Consequently, AUC for 
13C-butyrate were not different for both meals 
(P=0.65). 
The proportion of 
13C-acetate of total 
13C-SCFA in plasma was 99% after barley 
kernels and 98.3% after barley porridge. 
 
  125 
APPENDIX 4.  TYPE OF CARBOHYDRATES AND SCFA PROFILES 
 
Figure 2 Mean plasma enrichments 
13C-acetate (A), 
13C-propionate (B) and 
13C-
butyrate (C) after a barley kernels (          ) and barley porridge (           
) test meal (n = 5 subjects; mean ± sd) 
 
A 
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B   
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C 
 
 
 
 
Excretion of 
13C-SCFA in urine 
 
Figure 3 (A-C) shows the cumulative urinary excretion of the respective 
13C-
SCFA. Cumulative 
13C-acetate excretion after 24 h was similar after both meals 
(P=0.57). However, after barley porridge, 
13C-acetate excretion proceeded 
somewhat faster than after barley kernels, which is in agreement with the higher 
13C-acetate plasma concentrations in the early phase. Unlike in plasma, 
13C-
propionate was retrieved in urine after both meals although in lower 
concentrations after barley kernels. A tendency towards a significantly higher 
cumulative excretion after barley porridge than after barley kernels was observed 
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(P=0.098). The cumulative excretion of 
13C-butyrate was borderline significantly 
higher after barley kernels (P=0.057). 
Also in urine, 
13C-acetate was by far the most predominant 
13C-SCFA (97.4% 
of total 
13C-SCFA after barley kernels and 93.5% after barley porridge). 
 
Discussion 
 
In vitro fermentation studies using human (36-38) or swine inocula (39) have 
shown that the amounts and the pattern of SCFA production vary among 
different types of fermentable carbohydrate. For example, hydrolyzed guar gum 
produced the greatest amount of total SCFA and was involved in high production 
of propionate and butyrate whereas psyllium husk was involved in high 
production of butyrate. Similarly, the type of non-digestible carbohydrate 
consumed was found to influence the distribution of SCFA in the hindgut of rats 
(40). Rats fed pectin had a high proportion of acetic acid in the cecum whereas 
those fed guar gum had a higher proportion of propionic acid. In addition, 
combination of carbohydrates drastically changed the SCFA profile.  
Due to the inaccessibility of the colon in healthy, free-living humans it is 
extremely difficult to estimate the production profile of SCFA in the colon and 
their bioavailability to the host in humans. Faecal concentrations of SCFA do not 
adequately reflect their production because of the high absorption in the colon. 
Stable isotope tracer techniques with isotope dilution have been suggested as a 
way to estimate the colonic acetate production (41) and the whole body acetate 
flux (33). Ahmed et al. studied colonic SCFA formation in patients with left-sided 
colectomy and found a higher SCFA production and in particular butyrate 
production after a high-resistant starch diet as compared to a low-resistant starch 
diet. As yet, no data is available on the bioavailability of SCFA in the systemic 
circulation.  
In the present study, we have developed a new strategy in which plasma and 
urine concentrations of 
13C-labelled acetate, propionate and butyrate were 
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measured after administration of two stable isotopically labelled carbohydrate 
test meals, barley porridge and barley kernels. Barley porridge is rich in NSP 
whereas barley kernels contain resistant starch in addition to NSP. The 
13CO2-
excretion data showed that the porridge test meal was digested faster as 
compared to the kernel test meal (shorter time to peak excretion) which is in 
agreement with the higher amount of rapidly available glucose in the porridge 
meal as revealed from the in vitro starch fractions analysis.  In contrast, the 
extent of digestion and fermentation was relatively similar for both test meals 
(similar cumulative 
13C-excretion). The amount of substrate reaching the colon 
may have been similar in both occasions; however, the profile of enriched SCFA 
in plasma differed depending on the test meal administered. Whereas only 
13C-
acetate and 
13C-butyrate were found after administration of barley kernels, 
13C-
actate, 
13C-propionate and 
13C-butyrate were observed after administration of 
barley porridge. Based on several in vitro and in vivo studiessuggesting that 
resistant starches are good sources for butyrate production (38;42-44), we 
assume that colonic 
13C-butyrate production was higher after the barley kernels 
meal than after the porridge meal. Nevertheless, plasma 
13C-butyrate 
concentrations were rather similar after both meals.  A similar pattern was 
observed in urinary 
13C-butyrate excretion up to 12 h. However, urinary 
13C-
butyrate excretion from 12 to 24h tended to be higher after barley kernels than 
after barley porridge (P=0.74). These results suggest that butyrate production in 
the colon prodeeds slower than acetate or propionate production. This might be 
explained by the fact that butyrate is not produced directly from the fermented 
carbohydrate but through conversion of acetate (so-called mechanism of cross-
feeding)(45;46).  
In vitro studies have shown that fermentation of barley derived β-glucans by 
human faecal microbiota yields SCFA in a molar ratio of 
acetate:propionate:butyrate of 51:32:17 (47), which is considered propionate-
rich. However, the 
13C-SCFA were retrieved in plasma as well as in urine in a 
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molar  
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Figure 3  Mean urinary enrichments of 
13C-acetate (A), 
13C-propionate (B) and 
13C-butyrate (C) after a barley kernels and barley porridge test meal 
(n=3 subjects; mean ± sd) 
A 
 
B 
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ratio of acetate:propionate:butyrate of 98:1:1, reflecting differential absorption 
and metabolism in colonic epithelial cells and liver. 
Data on 
13C-enrichment of SCFA in urine confirmed the observed difference 
in SCFA profile after the two test meals. Interestingly, 
13C-enriched propionate 
was also observed in urine after the barley kernel test meal although to a lower 
extent than after the porridge meal. The measurement of low 
13C enrichment 
involves subtraction of basal 
13C abundance from each analysis. At low SCFA 
concentrations (as occurs with propionate and butyrate) this results in larger 
errors in estimating enrichment. However, the generally good agreement 
between plasma and urinary data, which were analysed in different laboratories, 
suggests that analysis of urinary SCFA enrichment profiles provides an adequate 
and non-invasive way to monitor the availability of SCFA to the host. This 
observation confirms previous data in which a similar whole body acetate flux 
was obtained from measurement of urine or plasma tracer enrichments (33). 
The orocecal transit time of both test meals was measured to allow 
correlation of changes in plasma 
13C-SCFA concentrations to the digestion 
phase (before OCTT) or the fermentation phase (after OCTT). OCTT values 
were similar for both test meals and amounted to approximately 6h. 
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When looking at the kinetics of appearance of 
13C-labelled SCFA in the 
circulation, it was found that plasma concentration of 
13C-acetate was already 
increased as early as after 3h, i.e. during the digestion phase (<6h). This 
observation could suggest that 
13C-acetate is derived from digestion of barley 
starch to glucose which undergoes glycolysis. However, during glycolysis, 
glucose is converted to pyruvate which, in aerobic conditions, enters the cell’s 
mitochondrion to be further oxidised to Acetyl-CoA which enters the Citric acid 
cycle. It is rather unlikely that free 
13C-acetate is formed during this process and 
Acetyl-CoA is not transported across the mitochondrial membrane. Alternatively, 
13C-acetate could be derived from early bacterial degradation of the test meal, a 
hypothesis which is favoured by the concomitant appearance of labelled 
propionate and butyrate, albeit to a lesser extent. All labelled SCFA were found 
in the 0-6h urine fraction as well, contributing to the hypothesis of early 
fermentation. It is not clear whether this early fermentation should be due to an 
easily fermentable compound of the test meal, to rapid transit of the head of the 
meal or to fermentation in the small intestine where, in the more distal parts, the 
density of bacterial populations lies between 10
4 to 10
8 cells/ml (as compared to 
10
12 cells/ml in the colon) (48).   
The methodology used in the present study allowed qualitative description of 
the SCFA reaching the circulation after consumption of a test meal rich in non-
digestible carbohydrates. To be able to relate colonic fermentation and SCFA 
availability to the effects of SCFA on peripheral tissues, it will be necessary to 
obtain quantitative results. Therefore, the methodology needs to be further 
adapted, probably by in vivo application of known quantities of isotope-labelled 
SCFA. 
In conclusion, the method described in this study allows to evaluate SCFA 
profiles obtained after administration of different non-digestible carbohydrates in 
healthy humans. The results of the present study have clearly shown that meals 
containing dietary fiber combined with resistant starch result in altered SCFA 
profiles as compared to meals containing dietary fiber alone. 
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SAMENVATTING 
 
SAMENVATTING 
De consumptie van koolhydraten is gerelateerd aan de preventie van type 2 
diabetes. Twee belangrijke fysiologische processen spelen hierbij een rol: a. 
vertering in de dunne darm: de verlaging van de postprandiale glucose respons 
(glucose respons na de maaltijd) en b. de fermentatie van niet-verteerbare 
koolhydraten in de dikke darm. 
Verondersteld wordt dat het fermentatie proces een rol speelt middels de 
korte keten vetzuren (kkv, met name acetaat, propionaat en butyraat). 
Uit onze experimenten bleek dat  gezonde mannelijke vrijwilligers die een 
avondmaaltijd met niet-verteerbare koolhydraten (gerstkorrels) hebben genuttigd, 
de volgende morgen (second meal effect) een verlaagde post-prandiale glucose 
respons hadden. Na de controle avondmaaltijd (wit brood) trad  ’s ochtends een 
door glucose geïnduceerde toename van de ontstekingsfactoren interleukin 6 
(IL6) en tumor necrosis factor (TNF)- α op. Deze werd echter niet waargenomen 
na de gerst-avondmaaltijd. De toegenomen waterstof productie en de verhoogde 
plasma butyraat spiegel suggereren sterk dat fermentatie in de dikke darm 
verantwoordelijk is voor deze gunstige eigenschappen met butyraat als 
intermediaire factor. (Hoofdstuk 1) 
Omdat een afgenomen insuline gevoeligheid en toename van pro-
inflammatoire cytokines geassocieerd zijn met de ontwikkeling van diabetes type 
2 en hart- en vaatziekten, suggereren onze resultaten dat fermentatie in de dikke 
darm belangrijk kan zijn voor de preventie van deze chronische ziektes en dit 
beschermend effect in het bijzonder optreedt bij niet-verteerbare koolhydraten 
met een speciaal kkv profiel. 
De literatuur is samengevat betreffende het belang van kkv voor insuline 
gevoeligheid en de mogelijkheid de fermentatie in de dikke darm zo te 
veranderen dat een optimaal kkv profiel wordt verkregen. 
Fermentatie in de dikke darm kan beïnvloed worden door 
voedingsveranderingen, veranderingen van de passage tijden van dunne en 
dikke darm, toepassing van remmers van dunne darm hydrolyse enzymen en 
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beïnvloeding van de activiteit en specificiteit van dikke darm bacteriën. Onze 
hypothese is dat de verhoogde insuline gevoeligheid gerelateerd is aan het kkv 
profiel. Verandering van het kkv profiel kan dus een target zijn om via voeding de 
insuline gevoeligheid te beïnvloeden en hetgeen preventief kan zijn voor de 
daaraan gerelateerde chronische ziekten. De functional foods die een kkv profiel 
produceren dat gelijk is aan dat van gerstkorrels, zouden  het vermogen hebben 
voor de verbetering van insuline gevoeligheid en preventie diabetes type 2. 
(Hoofdstuk 2) 
Het metabole effect van koolhydraten wordt bepaald door de mate waarin 
koolhydraten worden verteerd in de dunne darm en gefermenteerd in de dikke 
darm. Wij hebben een wiskundig model ontwikkeld om in vivo in de mens de 
vertering en fermentatie van koolhydraatrijke voedingen te bepalen. 
Dit model verschaft ons op een niet- invasieve manier een methode om de 
bijdrage van zowel vertering als fermentatie aan het totale metabole effect in 
kaart te brengen. Door gebruik te maken van 13C gemerkte voedingen kunnen 
wij een fermentatie index voor elke koolhydraatrijke voeding bepalen. Deze 
fermentatie index kan samen met de glycaemische index op een beknopte 
manier informatie verschaffen over de metabole karakteristieken van 
koolhydraatrijke voeding. (Hoofdstuk 3) 
De fermentatie van verschillende niet-verteerbare koolhydraten inclusief 
voedingsvezels is tot op heden niet goed beschreven. Om dit te bereiken is een 
analytische methode ontwikkeld om het kkv profiel in het perifeer bloed en urine 
te kunnen meten na inname van niet verteerbare koolhydraten. Wij gebruikten 
deze methode om na te gaan hoe het kkv profiel wordt beïnvloed door 
koolhydraat rijke voedingen. De testvoeding was gemerkt met stabiele isotopen 
waardoor wij de relatie konden leggen tussen de fermentatie producten en de te 
onderzoeken voeding. Wij vonden dat kkv profielen in plasma en urine konden 
worden veranderd door de verschillende niet verteerbare koolhydraten. 
(Hoofdstuk 4) 
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Ter conclusie, met deze nieuwe technieken om de fermentatie in de dikke 
darm te analyseren waren wij in staat het metabolisme van niet-verteerbare 
koolhydraten te onderzoeken in relatie met de verbetering van insuline 
gevoeligheid en preventie van type 2 diabetes. 
De relatie tussen fermentatie in de dikke darm en insuline gevoeligheid wordt 
door steeds meer gegevens ondersteund. Verandering van fermentatie van 
koolhydraten in de dikke darm lijkt een veelbelovende aanpak te zijn om de 
insuline gevoeligheid en de daaraan gerelateerde ziekten positief te beïnvloeden. 
Het design van een zg. ``second meal`` studie is een van de experimentele 
benaderingen om de gunstige effecten van voedingen rijk aan niet-verteerbare 
koolhydraten in kaart te brengen.  
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A  acarbose 
AB  gum A. baileyana 
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GC/C/IRMS  gas chromatorgraphy/combustion/isotope ratio mass 
spectrometry 
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